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Summary 
 
  Several conditions, from dietary metabolism to various disease 
states, induce changes of systemic acid-base balance. Excretion of fixed acid 
or alkali equivalentsinto urine is directed by the kidneys and critically 
participates in the regulation of blood pH homeostasis. The ammonium 
(NH4
+)/ ammonia (NH3) buffering system plays a major role to correct an extra 
acid load. In the collecting duct (CD) of kidneys, type-A intercalated cells 
mediate the removal of acids in the form of NH3 and protons (H
+) and produce 
new bicarbonate (HCO3
-). Urinary H+ secretion is mediated by active transport 
by vacuolar H+-ATPases (H+-ATPases). In the lumen,protonstrap NH3 
molecules, resulting in NH4
+ formation in urine. For long considered as a 
solely passive mechanism, the transport of NH3 in thecollecting duct of kidney 
is critically mediated by the NH3transporterRhCG. 
 In acid-loading conditions, mice deficient for Rhcg (Rhcg-/-) are not able 
to excrete a proper amount of NH4
+and show a more alkaline urine than 
wildtype animals.In humans, patients with impaired capacity to acidify urine 
develop distal renal tubular acidosis (dRTA). In particular, mutations affecting 
isoforms of the H+-ATPase found in kidney CD type-A intercalated cells cause 
the development of inherited forms of dRTA in humans and rodents.After a 
chronic acid-loading period, an incomplete form of dRTA also appears in 
Rhcg-/- mice. 
 
 The present dissertation aimed to understand the importance of RhCG 
in controlling systemic acid-base homeostasis. To this end, three projects 
were developed.  
 First, using a novel model of Rhcg+/+,+/-and -/- mice receiving a HCl diet 
for 2 or 7 days, we studied the effect of a single allele or complete deletion of 
Rhcg on acid-base status and NH3 transport across CCD cells, in order to 
determine to which extend Rhcg deficiency can induce metabolic acidosis. To 
clarify the role of Rhcg on the basolateral side of the CD cells, we 
assessedthe basolateral transport of NH3 inmicroperfused cortical collecting 
ducts of Rhcg+/+,+/-and -/- mice.Finally, adaptation mechanisms occurring in 
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kidneys of Rhcg+/+,+/-and -/- mice in response to the HCl acid-load were also 
inspected.  
 In a second project, we studied Rhcg+/+,+/-and -/- mice to determine the 
role of Rhcg in conditions of a physiological requirement for enhanced NH4
+ 
excretion into urine, such as the consumption of a high protein diet, which is 
typical of a western life style.  
 Finally, we examined the possibility of a functional interaction between 
Rhcg and vacuolar H+-ATPases in type-A intercalated cells of kidneys in order 
to detail the molecular pathway responsible for urinary acidification in the 
collecting duct of kidneys. 
 
 While Rhcg+/+ and Rhcg+/- were able to adapt a 2-days HCl acid-load in 
food, Rhcg-/-mice developedmetabolic acidosis with lower urinaryNH4
+and 
more alkaline urine. In addition,Rhcg+/- micealso developed metabolic 
acidosis after 7 days of HCl diet and most of the Rhcg-/- animals died before 
the end of the acid-loading period.Microperfusion studies of kidney cortical 
collecting ducts (CCDs) demonstrated that NH3 transepithelial permeability 
was reduced by 54% and 80% respectively in CCDs from Rhcg+/- and Rhcg-/- 
mice compared to wildtype, confirming that a 50% reduction of Rhcg activity is 
enough to impair the kidney collecting duct response to a strong acid-load, 
and result in chronic metabolic acidosis. The apical but also basolateral 
permeability of CCD cells of kidneys was reducedin Rhcg knockout mice, 
attesting for Rhcg function in basolateral transport of NH3.Rhcg
+/- mice 
exhibited a strong reduction in apical NH3 permeability only. Finally, reduced 
protein expression levels of the Na+/K+/2Cl- isoform 2 (NKCC2) co-transporter 
expressed in the thick ascending limb of the loop of Henle (TAL) was 
paralleled by lower concentrations of NH4
+ in the inner medullary tissue of 
Rhcg-/- mice, suggesting an influence of Rhcg on the NH3/NH4
+cortico-
papillary gradient formation or maintenance. 
 
 High protein diets from animal sources, which characterize the typical 
western diet, increase urinary NH4
+ excretion in kidneys. Harmfuleffects of 
protein-rich diets on bone and kidney function have been described in animal 
models and humans with normal and reduced kidney function. However, 
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mechanisms by which high protein diets act on renal acid excretion have not 
been examined in detail. We studied the impact ofanacid-loading high protein 
diet as casein (HC diet)on Rhcg+/+, +/- and -/- mice. After a transient decrease 
of blood pH and HCO3
- in all genotypes, we described a similaradaptation to 9 
days HC diet in Rhcg+/+and Rhcg+/- mice, which enhanced the Na+/glutamine 
co-transporter SNAT3 and the ammoniagenic enzyme PDG (Phosphate 
Dependent Glutaminase) involved inNH4
+ production in the proximal 
tubule.Rhcg-/-mice displayed an even stronger enhancement of these 
mechanisms, possibly as compensation.Non-acidogenic high protein diet as 
soy (HS diet) was used as a control and did not induce an acid-load 
ofRhcg+/+, +/- and -/-animals. In Rhcg+/+ mice,protein expression levels of 
NKCC2 and the H2O channel isoform 2 (AQP2)were decreased by 
theacidogenic HC diet paralleled by increased urinary volume. In Rhcg-/- 
compared to Rhcg+/+ mice, we observed higher NKCC2 protein expression as 
well as tissue NH4
+ concentration in the inner medulla after 4 days HC diet, 
but both were lowered after 9 days of the HC diet when higher urinary 
volumes were also observed. Our data suggest an original adaptive process 
of the kidney to an acidogenic high protein diet, involving a direct elimination 
of NH4
+ into urine, which seems to be exacerbated by the absence of Rhcg. 
Our data eventually showed increased signs of bone resorption in Rhcg-/-in 
the form ofhypercalcemia, hypercalciuria, increased deoxypyrydinoline (Dpd) 
and reduced bone mineral density in the cortical femur layer affected by HC 
diet.This study demonstrated the importance of Rhcg in the management of a 
physiological acid-load and suggests extra-renal effects of Rhcg. 
  
 In addition to reduced urinary NH4
+ excretion, Rhcg-/- mice had more 
alkaline urine. Accordingly, we observed in microperfused CCD from Rhcg-/- 
mice a defect in NH3 transport and a decrease in H
+ secretion compared to 
wildtype mice. We thus aimed to study a potentialfunctional interaction 
between Rhcg andthe multi-unit protein vacuolar H+-ATPase (H+-ATPase), 
which constitutes the main H+ transport system in the collecting ducttype-A 
intercalated cells.Rhcg-/-compared to +/+ did not display any differential mRNA 
expression regulation of various H+-ATPase subunits, but increased protein 
levels of B1 and reduced levels of the B2 isoform.Moreover, immunogold 
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electron-microscopy demonstrated similar subcellular localization of the 
ubiquitous A subunit of the vacuolar H+-ATPase. HEK293 cells 
overexpressing RhCG exhibited higher H+ fluxes compared to mock 
transfected cells together with enhanced levels of ATP6V1B1 mRNA. Finally, 
we investigated whether an opposite regulation could also occur by using an 
H+-ATPase inhibitor, concanamycin, and mice lacking the B1 subunit of the 
H+-ATPase (Atp6v1b1-/-) that display reduced H+-ATPase activity in CCD 
type-A intercalated cells.The H+-ATPase inhibitor concanamycin reduced both 
H+-ATPase and Rhcg activity in microperfused CCDs. However, Atp6v1b1-/- 
mice receiving 2 days HCl diet had lower H+-ATPase activity than wildtype, 
but revealedapical and basolateral NH3membrane permeabilities in 
microperfused CCD cells comparableto wildtype animals,attesting that a  
reduced H+-ATPase activityhad no impact on Rhcg activity. This study 
demonstrates a functional interaction where Rhcg is necessary forfullfunction 
of the vacuolar H+-ATPase in the collecting duct, although further experiments 
are needed to characterize this interaction. 
 
 In conclusion, this work confirms and details the central role of Rhcg in 
the final step of NH4
+excretion by the kidney and opens new perspectives 
regarding the role of Rhcg in the regulation of H+ transport by the collecting 
duct. 
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Deutsche Zusammenfassung der Doktorarbeit 
 
Multiple Faktoren, welche durch ein breites Kontinuum vom gesunden 
Metabolismus bis zu pathologischen Krankheitsbildern bedingt sind, können 
zu Veränderungen des systemischen Säure-Base-Gleichgewichts führen. Die 
Ausschüttung von fixen Säure- und Base-Anteilen in den Urin wird durch die 
Nieren gesteuert, damit spielen diese eine zentrale Rolle in der Regulierung 
der Homöostase des Blut pH-Wertes. Das Ammonium (NH4
+) / Ammoniak 
(NH3) Puffersystem ist bedeutend für die Korrektur von schwankenden 
Säureladungen. In den Sammelrohren der Nieren vermitteln Typ A 
Schaltzellen eine Reduktion von Säure indem sie NH3 und Protonen (H
+) aus 
dem Blut entfernen, während sie gleichzeitig Bikarbonate (HCO3
-) 
produzieren. Die H+-Sekretion wird durch einen aktiven Transport durch die 
vakuolare H+-ATPase vermittelt. Protonen werden durch NH3 Moleküle im 
Lumen eingefangen, dabei wird NH4
+ im Urin angereichert. Langezeit wurde 
angenommen, dass es sich dabei lediglich um einen passiven Mechanismus 
handelt, doch neuere Forschungsergebnisse zeigen, dass der NH3-
Transporter RhCG (Rhesus Blutgruppen-assoziiertes C Glykoprotein) eine 
wichtige Rolle für den Transport von NH3 in den Sammelrohren der Nieren 
spielt.  
In säuregeladenen Zuständen können Mäuse, die kein Rhcg (Rhcg-/-) 
besitzen, nicht die nötige Menge an NH4
+ ausscheiden und ihr Urin ist in der 
Folge stärker alkalisch als beim Wildtyp. Menschen, welche in der Fähigkeit 
den Urin anzusäuren, eingeschränkt sind, können an einer distalen renal-
tubulären Azidose (dRTA) erkranken. Insbesondere Mutationen, welche die 
Isoform der H+-ATPase der Typ A Schaltzellen im Sammelrohr der Niere 
betreffen, können in einer erblichen Form der dRTA bei Menschen und 
Nagern resultieren. Nach einer chronischen Säureanreicherungsperiode, 
kommt es auch bei Rhcg-/- Mäusen zu einer eingeschränkten Form der dRTA.  
 
Das Ziel dieser Dissertation ist das Verständnis der Wichtigkeit von 
Rhcg für die Kontrolle der systemischen Säure-Base-Homöostase. Zu diesem 
Zweck wurden drei Projekte ins Leben gerufen.  
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Als erstes haben wir den Effekt der einzelnen und kompletten Deletion 
von Rhcg auf den Säure-Base-Haushalt und den NH3-Transport durch 
Sammelrohrzellen untersucht. Wir haben dazu ein neues Model von Rhcg+/+, 
+/- und -/- Mäusen, welche während 2 oder 7 Tagen eine HCl (Salzsäure) Diät 
erhielten, verwendet und analysiert inwiefern ein Rhcg Verlust zur 
metabolischen Azidose führt. Um sicherzustellen welche Rolle Rhcg auf der 
basolateralen Seite von Sammelrohrzellen spielt, haben wir den basolateralen 
Transport von NH3 in mikroperfusionierten kortikalen Sammelrohren von 
Rhcg+/+, +/- und -/- Mäusen beobachtet. Schliesslich haben wir auch 
Anpassungsmechanismen in den Nieren von Rhcg+/+, +/- und -/- Mäusen an die 
HCl Säureladung untersucht.  
In der Folge haben wir in einem zweiten Projekt an Rhcg+/+, +/- und /- 
Mäusen die Rolle von Rhcg in einer physiologischen Situation in der eine 
vermehrte Ausscheidung von NH4
+ in den Urin nötig wird, analysiert. Diese 
Erhöhung wird durch eine, für die westliche Lebensweise typische, 
proteinreiche Diät gefördert.  
Schliesslich wurde die Möglichkeit einer Interaktion zwischen Rhcg und 
der vakuolaren H+-ATPase in den Typ A Schaltzellen mit dem Ziel die 
unterliegenden molekularen Signalwege, welche für die Ansäuerung des 
Urins in den Sammelzellen der Nieren verantwortlich sind, zu verstehen, 
erforscht.  
 
Während sich die Rhcg+/+ und +/- Mäuse an die 2-tägige HCl 
Säurezufuhr in ihrer Nahrung anpassen konnten, entwickelten die Rhcg-/- 
Mäuse eine metabolische Azidose mit erniedrigter NH4
+ Sekretion und sie 
produzierten einem stärker alkalischen Urin. Zusätzlich haben auch die 
Rhcg+/- Mäuse innerhalb von sieben Tagen der HCl Diät eine metabolische 
Azidose entwickelt und die meisten Rhcg-/- Mäuse starben vor Ende der 
Säurezufuhrperiode. Die Mikroperfusionsstudien der Sammelrohre der Nieren 
zeigten, dass die transepithelialen Durchlässigkeiten für NH3 bei Rhcg
+/- 
Tieren zu 54 % und bei Rhcg-/- zu 80 % reduziert wurden, wenn diese mit 
dem Wildtyp verglichen wurden. Damit bestätigten wir, dass eine 50 %-ige 
Reduktion der Rhcg Aktivität ausreicht um die Antwort der Sammelrohre auf 
eine starke Säureanreicherung zu minimieren, in welchem Fall es schliesslich 
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zu einer chronischen metabolischen Azidose kommt. Die apikalen und 
basalen Permeabilitäten der Sammelzellen der Nieren wurden bei Rhcg-
Knockout Mäusen reduziert, was die Funktion von Rhcg im basolateralen 
Transport von NH3 bestätigt. Rhcg
+/- Mäuse zeigten lediglich eine starke 
Reduktion der apikalen NH3 Permeabilität. Schliesslich stellten wir parallel mit 
einer verminderten Proteinexpression der Na+/K+/2Cl- Isoform 2 (NKCC2) des 
Ko-Transporters des dicken aufsteigenden Tubulus der Henle-Schleife, auch 
eine verminderte NH4
+-Konzentration im inneren Markgewebe der Rhcg-/- 
Mäuse fest, was darauf hinweist, dass Rhcg einen Einfluss auf die Bildung 
oder Erhaltung des kortikopapillären NH3/NH4
+ Gradienten hat.  
 
Proteinreiche Diäten tierischen Ursprungs, welche für den westlichen 
Lebensstil typisch sind, erhöhen in den Nieren die Ausscheidung von NH4
+ in 
den Urin. Die schädlichen Effekte solcher Diäten, die insbesondere die 
Knochen und Nierenfunktion beeinträchtigen, wurden bereits in Tiermodellen 
und auch an Menschen mit normaler und reduzierter Nierenfunktion, 
untersucht. Die genauen Mechanismen, durch welche proteinreiche 
Ernährung sich auf die renale Säureausscheidung auswirkt, wurden bisher 
nicht im Detail etabliert. Wir haben den Einfluss einer säureanreichernden 
proteinreichen Ernährung wie Käsein auf Rhcg+/+, +/- und -/- Mäuse erforscht. 
Nach einer vorübergehenden Senkung des Blut-pHs und HCO3
- in allen 
Genotypen, haben wir eine ähnliche Adaptation von Rhcg+/+ und +/- bei einer 
9-tägigen proteinreichen Ernährung festgestellt. Die Funktionen des 
Na+/Glutamin Kotransporters SNAT3 und des ammoniagenen Enzyms PDG 
(phosphate dependent glutaminase), welches in der Produktion von NH4
+ im 
proximalen Tubulus involviert ist, wurden erhöht. Rhcg-/- Mäuse haben dabei 
sogar eine stärkere Erhöhung dieser Mechanismen aufgezeigt, was 
möglicherweise der Kompensation dient. Eine nicht-säurehaltige proteinreiche 
Ernährung auf der Basis von Soja wurde als Kontrolle verwendet und hat 
keine Säureladung bei Rhcg+/+, +/- und -/- Mäusen induziert. Bei den Rhcg+/+ 
Mäusen wurde während einer säurehaltigen Diät, welche auf Käsein basierte, 
die Expression von NKCC2 und die Isoform 2 des H20-Kanals (AQP2) 
herunterreguliert, während das Volumen des Urins zunahm. Im Vergleich von 
Rhcg-/- Mäusen mit Rhcg+/+ Tieren zeigte sich, dass die NKCC2 Protein 
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Expression, sowie die NH4
+ Konzentration im Gewebe der inneren Medulla 
nach 4 Tagen der Käsein-Diät zunahmen, wobei die Expression bei beiden 
Gruppen nach 9 Tagen abnahm und wiederum höhere Urinvolumen 
beobachtet wurden. Unsere Ergebnisse deuten darauf hin, dass die Nieren 
anfänglich mit einem Anpassungsprozess auf die proteinreiche Diät 
reagieren, wobei NH4
+ direkt in den Urin ausgeschieden wird, diese 
Anpassung ist bei einem Fehlen von Rhcg eingeschränkt. Schliesslich haben 
wir bei den Rhcg-/- Mäusen auch erhöhte Zeichen von Knochenresorption in 
Form von Hyperkalzämie, Hyperkaliurie, und erhöhter Deoxypyridinoline 
(Dpd) und verminderter Knochendichte in der kortikalen Schicht des Femurs 
der Versuchstiere als Folge der proteinreichen Diät beobachtet. Diese 
Ergebnisse unterstreichen die Wichtigkeit von Rhcg in der Regulierung des 
physiologischen Säure-Base-Haushalts und lassen uns vermuten, dass Rhcg 
auch ausserhalb der Niere Einflüsse hat.  
 
Nebst der reduzierten NH4
+ Exkretion werden die Rhcg-/- Tiere auch 
durch einen basischeren Urin charakterisiert. In diesem Zusammenhang 
konnten wir bei den Rhcg-/- Tieren im Vergleich mit dem Wildtyp auch einen 
Defekts des NH3 Transports und eine gleichzeitige Verminderung der H
+ 
Sekretion beobachten. Aufgrund dieser Feststellungen wollten wir eine 
potentielle funktionelle Interaktion zwischen Rhcg und der vakuolaren Multi-
Unit-Protein H+-ATPase (H+-ATPase) untersuchen. Die H+-ATPase ist das 
Haupttransportsystem in den Typ A Schaltzellen der Sammelrohre. Beim 
Vergleich von Rhcg-/- und +/+ konnten wir keinen Unterschied in der mRNA 
Expression der Regulation der verschiedenen Untereinheiten der H+-ATPase 
feststellen, doch die Proteinmenge von B1 war erhöht, während die B2-
Isoform durch eine verminderte Proteinmenge charakterisiert wurde. 
Schliesslich zeigte die Immunogold-Elektronenmikroskopie eine ähnliche 
intrazelluläre Lokalisation der A-Untereinheit der vakuolaren H+-ATPase. 
HEK293 Zellen, welche vermehrt RhCG expressionierten, zeichneten sich 
durch höhere H+-Ströme aus, wenn wie mit Zellen, welche nur vorgetäuscht 
transfizierten wurden, verglichen wurden und auch die Menge an ATP6V1B1 
mRNA war in den Rhcg Zellen erhöht. Schliesslich haben wir auch 
untersucht, ob der Gebrauch eines H+-ATPase Inhibitors, Cocanamycin, zu 
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einer entgegengesetzten Regulation führen könnte und ob Mäuse, die keine 
B1-Untereinheit der H+-ATPase (Atp6v1b1-/-) besitzen, eine reduzierte H+-
ATPase Aktivität in den Typ A Schaltzellen des Sammelrohres aufzeigen. Der 
H+-ATPase Inhibitor Concanamycin reduzierte gleichzeitig die Aktivität der H+-
ATPAse und Rhcg in mikroperfundierten Sammelrohren. Atp6v1b1-/- Mäuse, 
welche während 2 Tagen eine HCl Diät erhielten, zeigten im Vergleich mit 
dem Wildtyp, eine verminderte H+-ATPase Aktivtät, doch die apikale und 
basolaterale NH3 Permeabilität der Membranen der mikroperfundierten 
Schaltzellen in den Sammelrohren blieb unverändert, was zum Schluss führt, 
dass die Reduktion der H+-ATPase Aktivität keinen Einfluss auf die Aktivität 
von Rhcg hat. Diese Arbeit enthüllt damit eine funktionelle Interaktion, welche 
von Rhcg abhängig ist. Rhcg ist bedeutend für die volle Funktion der 
vakuolaren H+-ATPase des Sammelrohrs. Für eine genauere 
Charakterisierung dieser Interaktion sind weitere Experimente notwendig.  
 
Diese Dissertation bestätigt und erläutert die zentrale Rolle von Rhcg 
im letzten Schritt der NH4
+ Sekretion in den Nieren und eröffnet gleichzeitig 
neue Perspektiven bezüglich der Rolle von Rhcg in der Regulation des H+-
Transports im Sammelrohr der Niere. 
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I   Introduction 
  
 Although ammonia (NH3) was not characterized as a gas before 1774
1, 
as early as in the Middle Ages, the presence of ammonium (NH4
+) in urine 
was known. Textile dyers used natural dyes from plant and animal sources to 
obtain colored fabric. The majority of those dyes required the use of a 
“mordant”, a chemical entity enabling the fixation of the dye to the fabric, like 
urinary NH4
+from fermented urine2.  
More than 1000 years later, in 1921, the physiological role of urinary NH4
+ 
started to be elucidated by Nash and Benedict who proved that NH3 is 
produced by the kidney and serves as a blood acidity buffering system3. In 
1945, Robert Pitts described the role of NH4
+ excretion in renal acid 
elimination, postulating that NH3 diffuses across the luminal membrane of 
epithelial cells following a passive diffusion process4,5. This knowledge 
remained unchanged until 2000 when Marini et al. provided the first 
experimental evidences for a proteindirectly responsible for NH3transport 
across cells in humans6. 
 
 In 2008, Biver and co-workers characterizedin vivo the first and so far 
only protein known to be responsible for NH3 passage in the kidney collecting 
duct: the Rhesus factor glycoprotein C, RhCG7. This dissertation presents the 
main findings following this seminal study and clarifies the role of RhCG in 
systemic acid-base homeostasis maintenance. 
 
I.1 The role of the kidneys in acid-base balance 
 
 In a normal subject, acid-base balance is permanently challenged by 
respiratory and metabolic alterations. Respiration discharging CO2 or dietary 
intake and metabolism constantly modify blood chemical composition, and, in 
particular, blood pH homeostasis. A tight control of systemic acid-base status 
plays a critical role in maintaining a stable state of the entire body and 
individual cells to ensure the essential living functions8. Outside an acceptable 
range of pH, proteins are denaturated and enzymes loose their ability to 
  
13 
function. To maintain a proper digestive function, the gastric acid pH must 
range from 1.5 to 3.5. With a pH of 4.8, the intracellular organelles lysosomes 
are able to properly break down waste material and cellular debris.  
In physiological conditions, the respiratory system gives the fastest response 
to prevent dramatic changes of the normal blood pH value (7.4). To regulate 
pCO2,the lungs are responsible for the exhalation of CO2 through the lung 
epithelium. When ventilation problems occur and blood pCO2 cannot be 
properly controlled, increased pCO2 leads to respiratory acidosis where the 
blood pH value drops belowpH 7.4. A reduced pCO2 would increase blood pH 
above the value of 7.4, therefore inducing respiratory alkalosis9. 
 
 Despite the critical action of the respiratory system in maintaining 
proper acid and base levels of the inner compartment, the equilibrium would 
be precarious without the non-volatile organism buffering system. The major 
blood buffering entity is bicarbonate (HCO3
-). While HCO3
- is permanently 
produced and regenerated, extra acid or alkaline loads are cleared from the 
blood. The kidney is the organ responsible for this maintenance of the 
organisms buffering power. Kidneys are also responsible for other essential 
processes: blood filtration, eliminationof toxic substances and returning of the 
useful ones, and blood pressure management. They also secrete different 
hormones involved in erythropoiesis, calcium absorption and blood pressure 
regulation10. The functional unit of kidneys, the nephron, consists of a 
glomerulus and a tubule. Blood is first filtrated through the glomerulus and the 
filtrate reaches later the tubular compartment. The tubule is an epithelial 
structure shaped of many subdivisions designed to convert the glomerular 
filtrate into urine. The composition of the glomerular filtrate shows the same 
solute concentrations than plasma with similar amounts of low molecular 
weight proteinsand less high molecular weight compounds and protein-bound 
solutes. The kidney requires a large glomerular filtration rate (GFR) of 
125mL/min in order to eliminate rapidly body wastes present in the plasma 
and potential toxic materials9. 
 
 At the level of the tubule, three interrelated mechanisms take place to 
cope with either excess acid loads produced by metabolism, diet and 
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intestinal losses or to handle an alkaline charge:  the reabsorption of HCO3
- 
filtered from the blood, the de novoformation of HCO3
- and the elimination of 
excess acid or alkali into urine via the production and excretion of protons and 
protons-binding buffers in different parts of the nephron.  
 
 Almost 80% of the filtered HCO3
- is reclaimed virtually along the 
proximal tubule. Most of the protons (H+) that the proximal tubule secretes via 
the Na+/H+ exchanger isoform 3 NHE3 and vacuolar H+-ATPases titrate the 
filtered HCO3
-forming H2CO3, which is, in turn, dissociated by the membrane-
bound enzyme carbonic anhydrase IV to yield CO2 and H2O. The water 
channel Aquaporine isoform 1 (AQP1) is then responsible for the apical 
transport of CO2 and H2O into the proximal tubule cells. The cytoplasmic 
carbonic anhydrase II enzyme catalyzes the formation of H2CO3from CO2 and 
H2O, which, ultimately, dissociates into H
+ and HCO3
-11. The HCO3
-ions 
produced are reabsorbed by the basolateral electrogenic Na+/HCO3
- co-
transporter isoform 1(NBCe1) and replace the consumed molecules.The 
remaining HCO3
- is reabsorbed by the thick ascending limb of the Loop of 
Henle (TAL) and, to a smaller extent, by the distal nephron.  
 
 Excess acids are buffered by ammonium (NH4
+) and titratable acids 
before their excretion into urine12. The kidney filters titratable acids, mostly 
represented by phosphate, creatinine and urate, which bind protons and trap 
them in urine. The NH3/NH4
+ system is more complex and plays a major role 
in renal acid-base regulation. NH3 is generated by the kidney andbinds 
protons at the level of the proximal tubule to form NH4
+, which is excreted in 
the lumen and later reabsorbed by the TAL into the renal interstitium where it 
accumulates to create a cortico-papillary gradient of NH3/NH4
+. Finally, NH3 is 
excreted into the lumen of the collecting duct where H+ are trapped, leading to 
the excretion of acid in the form of NH4
+. Protons not buffered by titratable 
acids and NH3cause urinary acidification. 
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I.2 Regulation of renal ammoniummetabolism 
 
 NH4
+is first produced in the proximal tubule cellsessentially by the 
metabolism of amino acids and mainly glutamine. In the proximal tubule, 
glutamine enters the epithelial cells through the Na+/glutamine co-transporter 
SNAT3, and, later on, enters the mitochondria. NH3 is then produced from 
glutamine by a cascade of deaminations involving the mitochondrial enzymes 
PDG (Phosphate Dependent Glutaminase) and GDH (Glutamine 
dehydroxylase) and producing α-ketoglutarate13,14.Inside the cytoplasm of the 
proximal tubule cells, the NH3 molecules produced bind protons to form NH4
+. 
α-Ketoglutarate is ultimately converted to oxaloacetate, which in turn is 
converted to phosphoenolpyruvate and carbon dioxide via the action of 
phosphoenolpyruvate carboxykinase (PEPCK), a cytosolic gluconeogenic 
enzyme. These reactions ultimately lead to HCO3
− generation and glucose 
production in the proximal tubule cells15,16. On the apical pole of the proximal 
tubule cells, the Na+/H+ exchanger isoform 3, NHE3, drives most of the 
NH4
+produced in the cells into the lumen, the remaining part reaching the 
renal vein where NH4
+will be detoxified by the liver to urea and glutamine17.  
 
 After its production and active secretion into the luminal fluid, most of 
luminal NH4
+ is then reabsorbed into the interstitium by the thick ascending 
limb (TAL) of the Loop of Henle to create a cortico-papillary gradient of NH3 
and NH4
+18. Transcellular pathways chiefly reabsorb the bulk of NH4
+ in this 
segment. On the luminal side, the main mechanism is achieved by the apical 
Na+/K+/2Cl-isoform 2 NKCC2 co-transporter19while the basolateral Na+/H+ 
exchanger isoform 4 NHE420 and the electroneutral Na+/HCO3
- coptransporter 
isoform 1 (NBCn1, not represented in Figure 1) are involved in the NH4
+ 
reabsorption and final accumulation in the interstitial tissue21. 
 
 The final step of the NH4
+ route along the nephron occurs in the distal 
nephron segments. An increasing gradient of NH4
+ is formed in the 
connecting tubule (CNT), the cortical collecting duct (CCD), the outer 
medullary collecting duct (OMCD) and the inner medullary collecting duct 
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(IMCD). In the collecting duct, type-A intercalated cells mediate acid secretion 
and bicarbonate reabsorption. Acids are excreted in urine the form of protons 
by active transport of H+ mostly operated by vacuolar H+-ATPases (H+-
ATPases)22. The titration of protons in the form of NH4
+in the final urine result 
from NH3diffusion and, more importantly, from NH3 transport into the lumen by 
the Rhesus factor glycoprotein C (RhCG)23,24. 
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Figure 1.Mechanisms of NH4
+
 synthesis and transport in the kidney 
Proximal tubule cell model.From glutamine entering inside the cell via SNAT3, the 
mitochondrial ammoniagenic enzymes PDG and GDH allow the production ofα-ketoglutarate 
and NH4
+
.Alpha-ketoglutarate is converted to oxaloacetate, which is ultimately transformed to 
glucose and HCO3
-
bythe gluconeogenic enzyme PEPCK.NH4
+
 passage into the luminal fluid 
results from NH3 diffusion and NHE3-driven NH4
+
 and H
+
secretion. Glutamine (Gln); 
Phosphate-dependent glutaminase (PDG); Glutamate (Glu); Glutamine dehydrogenase 
(GDH); α-ketoglutarate (αKG); Oxaloacetate (OAA); Phosphoenolpyruvate carboxykinase 
(PEPCK); Na
+
/H
+
 exchanger isoform 3 (NHE3). 
In the TAL, NH4
+
 reabsorption involving NKCC2 at the apical membrane and NHE4 on the 
basolateralside concentrates NH4
+
 in the medullary tissue. In the final step of renal NH4
+
 
handling, RhCG transports NH3 while H
+
-ATPases mediate H
+
 excretion. This process is 
critical in the kidney CD (CCD, OMCD and IMCD) to eliminate urinary NH4
+
. Thick ascending 
limb (TAL); Na
+
/K
+
/2Cl
-
 co-transporter (NKCC2); Na
+
/H
+
 exchanger isoform 4 (NHE4); Rhesus 
factor glycoprotein C (RhCG); Cortical collecting duct (CCD); Outer medullary collecing duct 
(OMCD); Inner medullary collecting duct (IMCD). Modified from reference25. 
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I.3 The renalammoniumtransporter RhCG 
 
 Ammonia transport into urine has been for long considered as a 
passive diffusion mechanism. In the recent years of physiology history, this 
paradigm has been however challenged by the characterization of a protein 
involved in urinary NH4
+excretion, the Rhesus factor protein RhCG. Rhesus 
glycoproteins are the animal equivalents of the bacteria, archea and plants 
Ammonia transport proteins (Amt) and Methylammonium permeases (Mep) in 
yeast. Amt and Mep proteins supply nitrogen to the cell in its bio-available 
form (NH4
+ or NH3), which is required for the synthesis of molecules such as 
amino acids or nucleic acids26,27.In animals, the Rhesus family is composed of 
the RhAG28, RhCE29 and RhD30 proteins found in erythrocytes and 
responsible for blood group identity, and the RhBG and RhCG homologous 
non-erythroid glycoproteins, which are expressed in a wide variety of tissues 
including kidneys. 
 
 In mouse and rat kidney RhBG is localized at the basolateral side of 
the distal convoluted tubule (DCT),the connecting segment (CNT) and the 
collecting duct cells. In the collecting duct, principal and type-A intercalated 
cells express RhBG, except for the IMCD where the protein is not detected in 
principal cells31. RhBG has also been recently reported in human kidney at 
the basolateral side ofthe CNT and in the cortical and outer medullary 
collecting ducts where the protein is only detected in type-A intercalated 
cells32.Heterologous studies have shown that RhBG is able to transport 
NH3
33.Mice with global Rhbgdeletion have normal basal acid–base 
parameters, normal responses to NH4Cl-induced metabolic acidosis, and 
normal basolateral NH3 and NH4
+ transport in microperfused CCD 
segments34. A more recent study performed on mice with intercalated cell-
specific Rhbg deletion showed that basal NH3 excretion of these mice was not 
altered, whereas an increase in glutamine synthetase expression was 
detected,suggesting that higher production of NH4
+in the proximal tubule may 
compensate for a NH4
+excretion in this mouse model in baseline conditions. 
However, in the same mouse model, urinary NH4
+excretion was impaired 
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following an acid-load35. Under specific conditions, RhBG may contribute to 
renal NH4
+excretion. 
 
 The RhCG protein is expressed in mouse and humans in the late DCT, 
in the CNT andall along the collecting duct of kidneys (CCD, OMCD and 
IMCD) in principal and type-A intercalated cells31,36,. In principal cells, which 
are not primarily involved in renal acid excretion, the role of RhCG is not 
elucidated. The basolateral and apical membrane of principal cells are 
permeable to NH3,with higherapical permeability, as revealedby confocal 
fluorescence imaging studies performed in perfused rabbit CCDs37. Although 
principal cells express less Rhcg than intercalated cells, increased principal 
cell Rhcg expression occurs in mice under chronic metabolicacidosis38. 
 
 First studies of Rhcg and Rhbg localization in mice described an 
opposite polarity of the proteins in the collecting duct with Rhbg expression at 
the basolateral side and Rhcg expression at the apical side31. Immunogold 
stainings performed later in mouse collecting duct cells revealed that Rhcg is 
expressed at both apical and basolateral poles ofCD type-A intercalated 
cells39. The crystallographic structure of the human RhCG protein has been 
resolved in 2010, and RhCG, like Amt and Mep proteins, has been 
characterized as a gas channel permeable to NH3
40. On the basolateral side 
of type-A intercalated cells, RhCG is expressed together with other proteins 
that are able to transport NH4
+ into epithelial cells: the Na+/K+-ATPases41 and 
the Na+/K+/2Cl- cotransporter isoform 1 (NKCC1)42.The anion exchanger 
isoform 1 protein (AE1) is also found at the basolateral pole and absorbs 
HCO3
- produced inside the cells together with H+from the action of carbonic 
anhydrase II (CAII)43. In the apical membrane, H+/K+-ATPases are able to 
transport NH4
+, but RhCG is responsible for most of NH4
+secretion. RhCG 
drives NH3 into urine while H
+ pumps (H+/K+-ATPases and mostly vacuolar 
H+-ATPases) are responsible for H+ exit, their combined action generating 
urinary NH4
+.  
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Figure 2. Collecting duct typeA-intercalated cell model 
On the basolateral side of type-A intercalated cells, Na
+
/K
+
-ATPases and NKCC1 mediate 
NH4
+
 uptake while NH3 enters the cell by diffusion and RhCG transport. AE1 absorbs HCO3
-
 
against Cl
-
 intake. Urinary NH4
+
 excretion results mostlyfrom NH3 passage mediated by 
RhCG and H
+
 active transport by H
+
/K
+
-ATPases and mostly, vacuolar H
+
-ATPases. 
Na
+
/K
+
/2Cl
-
 isoform 1 (NKCC1); Rhesus glycoprotein C (RhCG). Modified from reference 44. 
 
 In 2008, Biver and coworkers described RhCG as a new candidate 
gene for human distal renal tubular acidosis (dRTA)7. Both acute and chronic 
forms of metabolic acidosis have considerable adverse effects on renal 
cellular functions, impairing other cellular process implicated in different 
functions of the organism, like the cardiovascular system45. Renal tubular 
acidosis can be either proximal, due to impaired bicarbonate reabsorption, or 
distal, because of abnormal function of type-A intercalated cells and 
subsequent impairment of urine acidification46. The dRTA syndrome is 
characterized by normal anion gap metabolic acidosis with abnormally 
alkaline urine, hypokalemia, hypercalciuria and nephrocalcinosis47. dRTA 
patients present with a failure in NH4
+ secretion secondary to reduced urinary 
acidification by the collecting duct into the tubular lumen which 
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compromisesrenal acid excretionand acid-base homeostasis47.In human and 
rodent models, several genes have been linked to dRTA. Dominant forms of 
dRTA are generally less severe than recessive and have been associated 
with mutations of AE148. Two genes coding for 2 different subunits of the 
vacuolar H+-ATPase, ATP6V0A449 and ATP6V1B150 are linked with recessive 
dRTA. This later pathological condition appears in early infancy or early 
childhood with severe metabolic acidosis, growth retardation, and, if 
untreated, rickets47. In both cases of ATP6V0A4 and ATP6V1B1 mutations, 
dRTA is accompanied by the progressive apparition of sensorineural hearing 
loss50,51. 
 
 In their study, Biver et al. targeted the Rhcggene in mice, disrupting it 
by homologous recombination deleting 2 exons. After obtaining a full Rhcg 
knockout mouse (Rhcg-/-),the metabolic status of Rhcg+/+ and Rhcg-/- animals 
wasfirst investigated following an acid-load using 300mM NH4Cl in drinking 
water for 2 and 6 days. Inwild-type mice, the NH4Clacid-load induced a 
transient decrease of bloodpHand HCO3
-levels with partial recovery at day 
6,while Rhcg-/- mice could not adapt and showed decreased blood pH and 
HCO3
-levels during the entire treatment, indicatingan impaired ability to cope 
with the acid-load. In addition, reduced urinary NH4
+ excretion and more 
alkaline urine were observed in Rhcg-/- mice, features signing for dRTA.In 
Rhcg-/- mice receiving 200mM HCl diet during 7 days, a more severe 
metabolic acidosis, and impaired capacity to acidify urine accompanied by 
weight loss were found. Moreover, microperfusion experiments on outer 
medullary collecting ducts (OMCDs) and CCDs showed reduced apical 
permeability to NH3 and transepithelial NH3 transport in Rhcg
-/-, attesting tothe 
critical role of Rhcg in epithelial NH3 transport and renal NH4
+ excretion. 
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I.4 Aims of the dissertation 
I.4.1 Determination of the phenotype of Rhcg+/- mice, role of Rhcg in 
basolateral NH3 transport andrenal mechanisms of the adaptation 
to the lack of Rhcg 
 
 After the first in vivo characterization of the role of RhCG by Biver and 
colleagues,we aimed to perform a complementary study conducted on 
another model of Rhcgknockout mice. The first goal of this study was to 
determine whether or not a single deletion of Rhcg would affect the phenotype 
of Rhcg+/-. With this question, we tried to understand if heterozygous 
abnormalities of Rhcg would lead to dRTA similarly to what was observed 
previously in Rhcg-/- mice. 
 Some studies have demonstrated an exclusive expression of Rhcg at 
the apical membrane of the collecting duct cells31 whereas others detected 
the protein at both cellular sides52. Therefore, our second goal consisted of 
elucidating the controversial role of Rhcg in basolateral NH3 transport.  
 Finally, the renal mechanisms of the adaptation to the lack of Rhcg 
remained unknown. Consequently, the last goal of our study was to assess 
how NH4
+is accumulated in the medullary tissue as well as the regulation 
ofproteins involved in the NH4
+management of other nephron segments in 
partial or complete absence of Rhcg. 
 
I.4.2 Characterization of the response of Rhcg+/+, Rhcg+/- and Rhcg-/- 
mice to high protein diet 
 
 In physiological conditions, various conditions are known to affect renal 
NH4
+ excretion. Dietary K+ depletion has been linked to development of a mild 
alkalosis-like state resulting from enhanced renal ammoniagenesis and NH4
+ 
excretion in both animals and humans53-56. In the ammoniagenic pathway, the 
expression of SNAT3 is increased by K+ depletion, has shown recently57. 
Studies on rats have also demonstrated that Rhcg expression and apical 
versus basolateral abundance in OMCD intercalated cells increase in 
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response to low K+ diet, most probably contributing to increased NH4
+ 
excretion and alkalosis58. 
 
 Glucocorticoid and mineralocorticoid hormones, chiefly represented by 
cortisol and aldosterone, respectively, are also involved in acid-base 
homeostasis via regulation of renal NH4
+metabolism. Both hormones are 
produced by the adrenal gland. Cortisol is the major glucocorticoid hormone 
produced by the zona fasciculata of the adrenal cortex regulating 
gluconeogenesis and involved in suppression of the immune system and 
metabolism58. In the proximal tubule of kidneys, glucocorticoids stimulate 
ammoniagenesis60, an effect occurring through binding of the hormone to 
glucocorticoid receptors rather than mineralocorticoid receptors61. The 
mineralocorticoid hormone aldosterone is produced by the zona glomerulosa 
of the adrenal cortex and plays a central role in blood pressure regulation. 
Aldosterone acts on the distal convolutedtubule and collecting ducts by 
increasing the reabsorption of ions and water in the kidney in order to 
enhance the reabsorption of Na+, secretion of K+ andincrease water 
retention62. Known molecular targets of aldosterone action include the 
basolateral Na+-K+-ATPase and the apical epithelial sodium channel (ENaC), 
which are both critical for Na+ reabsorption. During the distal acidification 
process, aldosterone enhances Na+reabsorption but also H+-ATPases activity, 
leading to increased H+ excretion and luminal electronegativity63.  
 
 Protein-rich diets are known to induce a systemic acid load to which 
the kidney responds by increasing the net acid excretion and mainly urinary 
NH4
+ release64,65. Rich in sulphuric amino acids (SAA), methionine and 
cysteine, high protein diets from animal source induce an elevated production 
of H+ and sulphate (SO4
2-) when they are metabolised by the liver, resulting in 
increased blood acidity. To bring back a normal blood pH value, respiratory 
compensation occurs resulting in enhanced CO2 exhalation through the lungs 
while the kidneys play a critical role filtering and clearing SO4
2- from the blood, 
paralleled with increased urinary NH4
+ excretion64. 
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Figure 3. The metabolism of proteins from animal source increases urinary NH4
+
 
excretion 
Highly containing sulphuric amino acids (SAA), the consumption and metabolism of proteins 
from animal source by the liver induces a drop of blood pH that will be corrected by exhalation 
of CO2 through the lung and the critical action of the kidney via augmented excretion of NH4
+
 
into urine. Modified from reference 64. 
 
 The typical western diet contains high proportions of animal proteins 
and, in the recent years, high protein diets have become popular to fight 
excess weight and obesity. Therefore, the question of the impact of high 
dietary proteins on human health, especially on kidneys has become 
particularly relevant65-67. Detrimental effects of high protein consumption on 
chronic kidney disease (CKD) patients are clearly established68and the 
current protocol for these patients includes a reduction of proteins from animal 
sources to prevent a potential acceleration of renal function decline69,70. The 
normal functioning of kidneys is also modified by high protein diets. Rats fed 
high dietary protein as casein develop tubule-interstitial injury as a 
consequence of augmented intrinsic acid production provoked by endothelin-
stimulated enhanced aldosterone activity71-74. Moreover, high protein intake is 
also suspected to affect bone health75. Several clinical studies have 
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interestingly linked the consumption of high animal protein diets with 
enhanced bone resorption76. 
 
 The second part of the dissertation aimed at characterizing the effect of 
an acidogenic versus non-acidogenic diet on normal kidneys as well as 
understanding whether the lack of Rhcg induced a different response to those 
diets. Our first goal was to determine the impact of a high protein acid-load on 
metabolic parameters, and particularly urinary NH4
+excretion of Rhcg+/+, 
Rhcg+/- and Rhcg-/-mice. Our second aim consisted of searching for which 
mechanisms, renal or extra-renal, were responsible for the response to a 
dietary acid-load. 
 
I.4.3 Identification of a potential partnership between RhCG and the 
renal vacuolar H+-ATPase 
 
 In the collecting duct of kidney, type-A intercalated cells are primarily 
involved in renal acid excretion. In these cells, NH3 is mainly transported by 
facilitated diffusion through RhCG while protons are actively secreted into 
urine. H+ are formed inside the epithelial cells by the conversion of CO2 and 
H2O into HCO3
- and H+ resulting from the action of carbonic anhydrase II 
(CAII) (see figure 2). Two types of H+ pumps with ATPase activity are then 
responsible for H+ transport across the apical membrane: the H+/K+-ATPase 
and the vacuolar H+-ATPase (H+-ATPase)22. However, the role of H+/K+-
ATPase in H+ secretion across the CD membrane is minor compared to H+-
ATPases77.  
 
 Found ubiquitously in the organism vacuolar H+-ATPases play a large 
variety of roles depending where they are expressed. They regulate the pH of 
intracellular organelles such as lysosome, the Golgi apparatus, secretory 
vesicles and endosomes, allowing their proper functioning. H+-ATPases are 
also involved in synaptic transmission of neuronal cells78, they are found in 
osteoclasts, in macrophages, and regulate the extracellular pH of closed 
compartments in the inner ear79 and epididymis80. Eventually, they are found 
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in kidneys where they play a critical role in acid excretion. Renal vacuolar H+-
ATPases are found at the apical membrane of the proximal tubule, the TAL, 
the DCT and the type-A intercalated cells of the CCD, IMCD and OMCD 
where they allow H+ secretion. In the distal nephron, H+-ATPases are 
additionally present at the basolateral membrane of type-B intercalated cells 
where H+ absorption takes place22. 
 
 The vacuolar H+-ATPase is composed of 22 subunits consisting of two 
connected domains. The peripheral catalytic V1 domain contains 8 
subunits,named A-H, and converts ATP to ADP and inositol phosphate. The 
membrane-bound V0 domain contains 6 different subunits, a, d, c, c', c", and e 
and acts as a proton translocating channel. In the V1 domain, disruption of the 
B subunit in yeast leads to a conditional lethal phenotype, suggesting its 
essential role in H+-ATPase function81. Some subunits of H+-ATPases are 
expressed in a restricted number of organs and among them, B1, C2 and G3 
belonging to the V1 domain and a1, a2 and a4 form the V0 domain, are found 
in kidneys82.  
 
 In rat and mouse intercalated cells of the kidney CD, the B1 isoform of 
vacuolar H+-ATPases colocalizes with Rhcg36. Furthermore, in mouse and 
human, mutations of the genes coding for the a4 and B1 subunits of the 
vacuolar H+-ATPase cause inherited forms of dRTA49-51, a syndrome which 
also develops incompletely in Rhcg knockout mice7.  
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A      B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The vacuolar H
+
-ATPase is a multimeric protein expressing the B1 isoform in 
Rhcg positive type-A intercalated cells of kidney CCDs 
(A) Schematic structure of the vacuolar H
+
-ATPase. The H
+
-ATPase comprises 6 subunits 
(a, d, c, c’, c’’, e) in the V0 domain dedicated to H
+
 secretion and 8 subunits (A-H) in the 
cytoplasmic domain V1 mediating ATP hydrolysis. Modified from reference 83.  
(B) Immunostaings of Rhcg and B1 in rat OMCD cells. Among the 8 subunits (A-H) of the 
V1 domain, the B1 isoform of H
+
-ATPases is found specifically in intercalated cells of the 
kidney CD where Rhcg is also expressed. Vacuolar H
+
-ATPase (red), Rhcg (green), Merge 
(yellow). Taken from reference 36. 
 
 In the kidney type-A intercalated cells of kidneys, RhCG and H+-
ATPases display a coordinated action in order to eliminate NH4
+ into urine. At 
baseline conditions7 and following a 2 daysHCl acid-load39, Rhcg-/-mice show 
a more alkaline urine than Rhcg+/+ under the same conditions.Thus, our third 
goal was first to investigate the capacity of Rhcg-/- to excrete protons in urine. 
Reciprocally, we aimed to investigate the influence of an impaired proton 
excretion capacity by the vacuolar H+-ATPase on Rhcg mediated NH3 
excretion in the collecting duct of kidneys. We hypothesized that a potential 
functional interaction between RhCG and H+-ATPases may occur. 
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II  Haploinsufficiency of the ammonia 
transporter Rhcg predisposes to chronic 
acidosis - Rhcg is critical for apical and basolateral 
ammonia transport in the mouse collecting duct 
 
Article published: J. Biol. Chem., vol 288, N° 8, pp. 5518–5529, February 
22, 2013, DOI10.1074/jbc.M112.441782 
 
Own contribution to the publication: 
 
 The qRT-PCR evaluating Rhcg mRNA level in Rhcg+/+, +/- and -/- mice 
was performed and appears in Figure 1B. 
 Western blotting analysis was conducted on Rhcg+/+, +/- and -/- mice 
receiving 2 days of HCl acid-load to evaluate the expression levels of various 
proteins involved in ammoniagenesis and NH4
+ transport. Figure 8 shows 
PEPCK (Figure 8A), PDG (Figure 8B), NKCC2 (Figure 8C) and NHE3 
(Figure 8D) protein levels measured and compared between Rhcg+/+, +/- and -
/- mice. 
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III  The role of the renal ammonia transporter in 
metabolic responses to dietary protein 
 
 
Own contribution to the publication: 
 
 For the metabolic studies of Rhcg+/+, +/- and -/- mice performed inFigure 
1 and Supplementary Figure 1, blood pH (Figure 1A, Supplementary 
Figure 1A) and blood bicarbonate (Figure 1B and Supplementary Figure 
1B) were measured as well as urinary pH (Figure 1C and Supplementary 
Figure 1C) and NH4
+ concentration (Figure 1E and Supplementary Figure 
1C). 
 The mRNA and protein expression assessment realised in Figure 2 
and Supplementary Figure 2 in Rhcg+/+, +/- and -/- mice were all carried out. 
 Western blotting analysis as well as kidney tissue NH4
+ concentration 
measurement appearing in Figure 3, Figure 4 and Supplementary Figure 3, 
Supplementary Figure 4 were also all completed. Urinary volume evaluation 
was performed together with the metabolic studies presented in Figure 1. 
 All parameters presented in Figure 5were measured: ionized blood 
Ca2+ and osteocalcin levels as well as urinary Ca2+ and deoxypyrydinoline 
(Dpd) in Rhcg+/+ and -/- mice.  
 In Table 1 and Supplementary Table 2 showing the metabolic 
parameters of Rhcg+/+, +/- and -/- mice receiving respectively High Casein diet 
and High Soy diet, body weight, food intake, water intake, urine volume, 
urine pH, urinary creatinine, urinary NH4
+, and urinary Dpd were achieved 
as well as all blood values appearing in Supplementary table 1 and 
Supplementary table 4. 
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ABSTRACT 
 
High dietary protein imposes a metabolic acid load requiring excretion 
and buffering by the kidney. Impaired acid excretion in chronic kidney disease 
(CKD), with potential metabolic acidosis may contribute to the progression of 
CKD. Here we investigated the renal adaptive response of acid-excretory 
pathways to high protein diets containing normal or low amounts of acid-
producing sulphur-amino acids (SAA). We also examined how this adaption 
requires the RhCG ammonia transporter. Diets rich in SAA stimulated 
expression of enzymes and transporters involved in mediating 
NH4
+reabsorption in the thick ascending limb of the loop of Henle. The SAA-
rich diet increased diuresis paralleled by down-regulation of AQP2 water 
channels. The absence of Rhcg transiently reduced NH4
+ excretion, 
stimulated the ammoniagenic pathway more strongly, and further enhanced 
diuresis by increasing the down-regulation of the Na+/K+/2Cl-- cotransporter 
NKCC2 and AQP2 with less phosphorylation of AQP2 at serine 256. The high 
protein acid-load affected bone turnover, as indicated by higher Ca2+ and 
deoxypyrydinoline (Dpd) excretion, and changed tissue mineral density (TMD) 
in newly formed bone layers. Phenomena exaggerated in the absence of 
Rhcg. In animals receiving a high protein diet with low SAA content, the 
kidney excreted alkaline urine, with low NH4
+¨ and no change in bone 
metabolism. Thus, the acid-load associated with high protein diets causes a 
concerted response of various nephron segments to excrete acid, mostly in 
the form of NH4
+ requiring Rhcg. Bone metabolism is altered by a high protein 
acidogenic diet, presumably to contribute to buffering the acid-load.
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INTRODUCTION 
 
 The kidney is the central organ excreting acid and replenishing 
bicarbonate buffer used by metabolism 1-2. The importance of the kidney in 
acid-base balance is demonstrated by inherited and acquired renal diseases 
reducing its ability to excrete acid, reabsorb and synthesize bicarbonate 
(HCO3
-) 3-5. Recent studies suggest that the progression of CKD is delayed by 
alkalinizing therapies aiming to reduce the metabolic acidosis occurring with 
the disease 6-10. 
In Western diet, protein intake exceeds by up to 50% the 
recommended average daily consumption of 0.8g/kg/day of protein with most 
protein of animal sources which are rich in sulfur-containing acidogenic amino 
acids11-12. High animal protein diets have gained additional popularity in the 
context of obesity and its treatment 13-14. Adverse effects of high protein intake 
on many organs have been described,and particularly the negative impact on 
bone and the function of healthy kidney has been discussed controversially 15-
23. In kidney disease, high animal protein may accelerate decay of renal 
function, thus, current protocols strongly suggest reducing animal protein 
intake in CKD patients 24-26. 
 Dietary protein intake and its metabolism can provide a major acid 
load, however, the metabolic acid load depends on the nature and 
composition of the protein. Proteins rich in sulphur-amino acids (SAA, i.e. 
cysteine and methionine) release protons (H+) and sulfate (SO4
2-) during 
metabolism and cause increased renal acid and NH4
+ excretion paralleled by 
high urinary SO4
2- and urea removal 27-28. Plant proteins such as soy protein 
contain only small amounts of SAA and consequently cause a milder acid or 
even alkaline load 19, 29-30. The acid content of high protein diet has been 
linked to the development of tubular-interstitial injury secondary to augmented 
intrinsic acid production provoked by endothelin-stimulated enhanced 
aldosterone activity 29, 31-32. 
 The renal ammonia (NH3) transporter RhCG is critical to eliminate NH4
+ 
and maintain systemic acid-base balance 33-36. RhCG is localized in most cells 
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along the collecting duct and mediates basolateral uptake of NH3 and final 
excretion into urine. Its expression is stimulated by acidosis in mice and Rhcg 
becomes rate-limiting for urinary NH4
+excretion during strong acid-loads 
(NH4Cl or HCl-loading) 
33, 36-38.  
Here we examined the effect of high protein diets containing either 
acidogenic SAA (casein diet) or being almost devoid of these amino acids 
(soy protein diet) on renal mechanisms mediating ammoniagenesis and 
excretion of the acid-load. Our data demonstrate a concerted response of 
various nephron segments to eliminate the metabolic acid load, the 
requirement of Rhcg mediated NH4
+ excretion, and effects on bone, altogether 
providing a molecular explanation for the stimulation and requirement of renal 
acid excretion.  
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RESULTS 
 
High casein protein diet induces a transient acid load that Rhcg-/- mice 
can excrete  
Metabolic parameters and acid-base status were assessed in Rhcg+/+, 
Rhcg+/-, and Rhcg-/- mice receiving normal diet (basal status with 20 % 
protein), acid-loading High Casein (HC) protein diet or non-acid loading High 
Soy control protein diet (HS) containing either high or low sulfur amino acid 
(SAA), respectively. Fifty % of HC or HS diets were provided either as casein 
or soy protein but the diets were otherwise isocaloric and identical in their 
composition. HC but not HS diet was associated with slightly reduced food 
intake (Table 1 and supplementary Table 1). However, no difference was 
found in food and water intakes between the 3 different genotypes at all time 
points measured and under all 3 types of diet (normal, HC and HS) (Table 1 
and supplementary Table 1). Baseline blood and urine parameters (Table1 
and supplementary Tables 1-4) were similar between all 3 genotypes. A 
transient decrease in blood pH and HCO3
- after 2 days HC diet (Figure 1, A 
and B) but not HS diet (supplementary Figure 1, A and B) was identically 
observed in Rhcg+/+, Rhcg +/-, and Rhcg -/-, confirming the acid-loading effect 
of HC diet. HC diet did not alter urinary pH but stimulated excretion of 
titratable acidity, most likely in the form of phosphate (Table 1 and 
supplementary Table 2) to a comparable extent in all three genotypes (Figure 
1, C and D). In contrast, HS did not alter blood pH and HCO3
- but led to a 
profound alkalinisation of urine pH and a fall in the urinary excretion of 
titratable acids (supplementary Figure 1C, supplementary Table 1). Urinary 
NH4
+ excretion was markedly increased in the HC groups whereas it 
decreased in the HS groups (Table 1 and supplementary Table 1, Figure 1E 
and supplementary Figure 1D). Rhcg deletion delayed the increase in urinary 
NH4
+ excretion in response to the HC acid challenge (Figure 1E). At days 2 
and 4 HC diet, respectively, Rhcg-/- exhibited a 38.5%+/- 0.1 and 41.4% +/- 
0.1 decrease in excreted urinary NH4
+ compared to Rhcg+/+ mice (Table 1). At 
day 9, Rhcg-/- adapted to the HC diet acid load and excreted similar amounts 
of NH4
+ like Rhcg+/+ mice. HS diet did not induce any difference in urinary 
NH4
+ excretion in all 3 genotypes (supplementary Figure 2D). Taken together, 
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these data confirm that a diet containing high amounts of SAA causes a 
metabolic acid load and demonstrate that its elimination depends partially on 
the presence of the ammonia transporter Rhcg. 
 
High casein diet stimulates ammoniagenesis in theproximal tubule 
 To assess the proximal tubule response to HC diet we studied the 
regulation of key molecules involved in NH4
+ production and excretion (Figure 
2, A-D, Supplementary Figures 2 - 4). High Casein diet caused a transient 
increase in Rhcg mRNA, whereas Rhbg mRNA was not altered in Rhcg+/+ and 
Rhcg-/- kidneys. Four days HC induced a transient increase in SNAT3 and 
PDG mRNA levels compared with normal diet (Figure 2, A and C). SNAT3 
protein levels were also higher after 4 days HC diet while PDG showed a 
higher protein expression at day 9 HC diet (Figure 2, B and D). PEPCK and 
NHE3 protein abundance remained unchanged in Rhcg+/+ during HC 
treatment (Supplementary Figure 3, A and B). To test if the delayed 
adaptation to HC diet acid load observed in Rhcg-/- mice could be partly 
explained by an adaptive enhanced NH4
+ production, we compared SNAT3, 
NHE3, PDG, and PEPCK mRNA and protein abundances in all 3 groups of 
mice after 4 and/or 9 days HC diet. NHE3 and PEPCK mRNA and protein 
expression levels were comparable between all 3 genotypes (Supplementary 
Figure 3, C-H). However, at day 4 HC diet, both Rhcg+/- and Rhcg-/- increased 
mRNA and protein expression of SNAT3 compared to Rhcg+/+ (Figure 2, A,B, 
E, and F). PDG mRNA and protein were higher in Rhcg-/- than Rhcg +/+ (Figure 
2, C, D, G and H). After 9 days HC diet, SNAT3 and PDG mRNA and protein 
were still higher in Rhcg-/- than in Rhcg+/+ while in Rhcg+/- mice only PDG 
protein levels were elevated. Thus, Rhcg null mice increase expression of 
some proteins critical for proximal tubular ammoniagenesis.  
 
Rhcg+/-and -/- mice have abnormal accumulation of NH4
+ in the medullary 
interstitium 
 Next we assessed mechanisms involved in the generation of the 
cortico-papillary NH4
+ gradient hypothesizing that Rhcg-/- mice could increase 
the NH4
+ excretion by stimulating NH4
+ reabsorption by the thick ascending 
limb NKCC2 cotransporter.NKCC2 protein expression in Rhcg+/+, Rhcg+/-, and 
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Rhcg -/- mice after 4 and 9 days HC diet revealed two opposite regulations of 
the protein during HC treatment. NKCC2 levels were higher in Rhcg+/- and 
Rhcg -/- after 4 days (Figure 3A) but lower in Rhcg-/-after 9 days (Figure 3B). 
NH4
+tissue content incortex, outer medulla, and inner medulla followed 
NKCC2 expression. At day 4 HC (Figure 3C and D), both Rhcg+/- and Rhcg -/- 
accumulated more NH4
+than Rhcg+/+ in the inner medulla (+25.2 ± 0.1% for 
Rhcg+/- and +29.9 ± 0.1% for Rhcg-/-). In contrast, at day 9 HC (Figure 3D), 
Rhcg-/- had lower inner medullary NH4
+ content than Rhcg+/+ (-37.0 ± 0.1%). 
Thus, the adaption of Rhcg deficient mice to high SAA diet involves regulation 
of the NKCC2 cotransporter and affects accumulation of NH4
+ in the 
medullary interstitium. 
 
High casein diet stimulates diuresis and downregulates NKCC2 and 
AQP2  
 Besides its role in NH4
+ reabsorption, NKCC2 functions in the counter-
current mechanism establishing the cortico-papillary osmotic gradient required 
for water reabsorption along the collecting duct. HC diet induced diuresis in all 
three genotypes (Figure 4E, Table 1) whereas diuresis was lower in animals 
receiving the HS diet despite quantitatively similar urea excretion (compare 
table 1 and supplementary table 1). We measured NKCC2 and collecting duct 
AQP2 protein expression levels in Rhcg+/+ (Figure 4, A and B) and Rhcg -/- 
animals (Figure 4, C and D) at 0, 4 and 9 days HC and HS diet. NKCC2 and 
AQP2 were down-regulated by HC diet in both genotypes with reduced 
NKCC2 expression in Rhcg wild-type after 4 and 9 days HC (Figure 4A) and 
after 9 days in Rhcg null mice (Figure 4C). Similarly, AQP2 levels were lower 
after 9 days HC in Rhcg+/+ andRhcg-/- mice (Figure 4, B and D). Since Rhcg-/- 
excreted more urine than their littermates(5.7 ± 0.5 vs. 4.5 ± 0.3 mL/24h after 
9 days HC, p≤0.01) (Figure 4E) we tested if the active phosphorylated form of 
AQP2 (pSer256-AQP2) was altered in Rhcg-/- mouse kidneys. The total 
abundance of mature pSer256-AQP2 (35 KDa band) was reduced as well as 
the ratio of phosphorylated AQP2 over total AQP2 (Figure 4F). In animals 
receiving the HS diet, no regulation of NKCC2 and AQP2 was observed 
(supplementary Figure 4). In summary, high SAA diet stimulates diuresis by 
down-regulating NKCC2 and AQP2, an effect amplified in Rhcg-/- mice. 
  
50 
High casein diet stimulates bone resorption exaggerated by absence of 
Rhcg 
 Two days HC diet caused a transient increase in ionized blood Ca2+ 
levels in bothRhcg+/+ and Rhcg-/- animals but significantly higher in Rhcg-/- 
mice.  In contrast, Ca2+ levels remained higher in Rhcg-/- mice and returned to 
normal only on day 9 (Figure 5, A). Urinary Ca2+ excretion was also transiently 
increased in both genotypes at days 2 and 4 HC diet, with significantly higher 
urinary Ca2+ levels in Rhcg-/- at day 4 (Figure 5B). To investigate bone 
remodelling, we measured urinary deoxypyrydinoline (Dpd) excretion, a 
marker of bone resorption and plasma concentration of osteocalcin, a marker 
of bone formation (Figure 5C and D). Dpd levels were elevated after 4 days 
HC diet in Rhcg+/+ and Rhcg-/-and remained higher in Rhcg-/-after 9 days HC. 
No significant difference in plasma osteocalcin levels was found during the 
treatment and between the 2 groups suggesting that bone resorption in 
Rhcg+/+ and Rhcg-/- mice is not compensated by increased bone formation. To 
further evaluate the direct impact of acidogenic high protein diet on bones, we 
measured tissue mineral density (TMD) of the mid-cortical region of femurs 
collected after 9 days HC diet (Figure 6A and 6B). Micro-computed 
tomography (micro-CT) scans were analysed by comparing TMD of a deep 
bone layer mineralised before the HC diet period and therefore not influenced 
by the acidogenic protein load (layer 12) with TMD of a more superficial layer 
close to the periosteum which contained bone formed during the HC diet 
(layer 2) (Figure 6A). Surprisingly, TMD of layer 12 in Rhcg-/- mice (diet 
independent) was higher than the corresponding layer in femurs from Rhcg+/+ 
mice (1267.5 mhHA/cm3 vs. 1206.0 mhHA/cm3, p ≤ 0.01). TMD of layer 2 was 
lower in both Rhcg+/+ and Rhcg-/-. However, the difference between genotypes 
was not detected anymore in layer 2 (formed during HC diet), suggesting that 
a more pronounced reduction of mineral content occurred in Rhcg-/-mice 
induced by HC diet (917.4 mhHA/cm3 vs. 944.8, p ≥ 0.05) (Figure 6B). HS diet 
did not affect cortical mineral content of HS treated animals (data not shown). 
Moreover, no difference was detected in the standard morphometric 
parameters suggesting that all bones had similar size, shape and internal 
microarchitecture (supplementary table 5).  
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DISCUSSION 
 
In the current study we examined the effect of an acidogenic high protein 
diet on the renal adaption through acid excretion. We compared two different 
diets with high protein content (50 %) containing either normal levels of SAA 
(casein protein) or low levels of these amino acids (soy protein). Intake of 
these diets was similar in all groups as evident from total food intake and total 
urinary urea excretion 39. The dietary content of SAA is reflected by the 
excretion of SO4
2- in urine much higher in the animals ingesting the casein 
diet. Based on this animal model we find that the kidney adapts to the high 
SAA diet with a parallel response of various nephron segments: i) stimulated 
NH4
+ excretion and increased expression of key molecules of the 
ammoniagenic pathway in the proximal tubule, ii) reduced expression of the 
NKCC2 cotransporter, iii) increased diuresis and down-regulation of the AQP2 
water channel, iv) loss of bone TMD, and v) all processes being dependent on 
the ammonia transporter Rhcg as evident from reduced ammonium excretion, 
exaggerated induction of ammoniagenic molecules, enhanced diuresis and 
downregulation of NKCC2 and AQP2, and more severe effects on bone 
remodelling.  
 
Intake of high protein in the form of casein caused an increased urinary 
NH4
+ and titratable acid excretion and a transient fall in blood pH and HCO3
-
indicative for the metabolic acid load and the kidneys’ ability to adapt. In 
contrast, high soy protein reduced the dietary acid load as urinary NH4
+ and 
titratable acid excretion decreased and urinary pH became more alkaline. 
Interestingly, TA excretion increased strongly with the SAA diet and remained 
high. This is in contrast to humans and rodents provided with an acid load in 
the form of NH4Cl or HCl, respectively, where most acid is excreted in the 
form of ammonium 36, 40-41. These differences may be in part due to different 
types of acid-loading. 
 
The increased acid excretion found in animals fed with high acidogenic 
protein diet, was paralleled on the molecular level by a stimulation of 
expression of the glutamine transporter SNAT3 and the phosphate dependent 
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glutaminase in the proximal tubule. The regulation of SNAT3 by high protein 
intake had been reported previously 42. In contrast, PEPCK, fueling alpha-
keto-glutarate from ammoniagenesis into gluconeogenesis was decreased 
during high casein diet in Rhcg+/+ kidneys suggesting a decrease in renal 
gluconeogenesis. In rat liver, PEPCK is stimulated by high protein intake 
which might indicate that high casein intake induces specifically renal 
ammoniagenesis and favors hepatic over renal gluconeogenesis 43. 
 
 The response of the collecting duct system to high protein intake has 
been previously described, mostly based on functional experiments 
demonstrating increased H+ and NH4
+ secretion 31-32. Consistently, mice 
receiving high casein diet excreted high amounts of NH4
+ into urine. Rhcg 
mRNA abundance increased transiently (day 4) at the time where Rhcg-/- mice 
showed decreased urinary ammonium excretion suggesting that Rhcg may be 
directly regulated and mostly needed during the earlier phase of adaption. 
Similarly, during NH4Cl induced acidosis, Rhcg protein abundance is 
increased and staining enhanced at the luminal and basolateral membrane 
suggesting that Rhcg is regulated at different levels 44-45. Rhbg mRNA was not 
regulated consistent with previous data from NH4Cl-loaded mice and a less 
important role of Rhbg in renal ammonium excretion 45-47. This later process 
along the collecting duct requires the formation of a NH4
+ gradient from 
medullary interstitium into urine which is generated at least in part by the 
reabsorption of NH4
+ by the NKCC2 cotransporter in the thick ascending limb 
of the loop of Henle. This transporter is stimulated by acidosis induced by 
NH4Cl-feeding 
48-51. In contrast, high casein diet progressively decreased 
expression of NKCC2 without disturbing medullary NH4
+ accumulation. 
 
The renal adaptation to high casein diet was impaired in the absence of 
Rhcg. Rhcg-/- mice had a delayed increase in urinary NH4
+ excretion, required 
a stronger and more sustained increase in PDG and SNAT3 expression, all 
indicating highly stimulated ammoniagenesis. Furthermore, NKCC2 
expression was even more decreased than in wild-type animals and 
medullary NH4
+ accumulation was impaired in the inner medulla.  
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High protein diets, casein and soy, stimulated diuresis in animals, 
however, casein produced a stronger diuresis than soy diet. Increased 
excretion of urea from hepatic protein metabolism may be in part responsible 
for the diuresis causing an osmotic driving force. The acid content of the high 
casein diet, however, provides likely an additional stimulus since mice 
receiving the acidogenic casein diet had higher diuresis despite almost 
identical urea excretion. Indeed, feeding mice or rats with NH4Cl causes a 
similar diuresis 52-53. Here we found that diuresis was accompanied by a 
progressive reduction in AQP2 water channel expression. Rhcg-/-mice 
excreted even higher urine volumes than Rhcg+/+ animals. No regulation of 
NKCC2 and AQP2 was observed in mice receiving the HS diet demonstrating 
that high protein per se does not regulate these proteins. Moreover, 
phosphorylation of AQP2 at serine 256, critical for the regulated insertion and 
activity of the channel in the membrane, was reduced in knock-out mice 
suggesting that increased diuresis may be part of a compensatory 
mechanism. Thus, the more pronounced reduction in NKCC2 expression and 
reduced insertion of AQP2 at the plasma membrane would allow Rhcg-/- mice 
to excrete the NH4
+ formed in the proximal tubule by shunting the medullary 
interstitium passage, diluting and excreting the NH4
+ load in the thick 
ascending limb and collecting duct. The time course of achieving similar rates 
of urinary ammonium excretion and stronger downregulation of NKCC2, 
reduced medullary ammonium accumulation, and lower AQP2 expression is 
similar, possibly indicating a concerted compensatory mechanism. We 
speculate that several hormones might be involved in mediating the effect of 
HC diet on NKCC2 and AQP2. Among them, aldosterone, endothelin, 
prostaglandin E2 (PGE2) and atrial natriuretic peptide (ANP) have been shown 
to be increased by high protein diets 32, 54-55. ANP and PGE2 reduce AQP2 
expression and NKCC2 function 56-57. Also endothelin and aldosterone may 
reduce NKCC2 expression and function via a NO, cGMP and PDE2 
dependent mechanism. 
 
The beneficial or detrimental effects of high protein diets on bone are 
controversial and the positive or negative impact may depend on the type of 
protein, the content of minerals, and the content of carbohydrates (e.g. 
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whether diets are ketogenic) 21-23. Acidosis has significant adverse effects on 
bone, stimulating osteoclast activity, increasing demineralization, and finally 
leading to loss of bone mineral density and stability 58-59. The high casein diet 
stimulated bone degradation in Rhcg-/- as evident from the increased urinary 
excretion of deoxypyrydinoline and reduction of bone tissue mineral density in 
a layer close to the bone surface and hence containing newly formed bone. In 
wild-type animals, Dpd levels increased only transiently, whereas in Rhcg-/- 
mice, Dpd remained elevated consistent with increased bone degradation 
possibly contributing to the compensation of reduced NH4
+ excretion. 
Surprisingly, no evidence was found for higher osteoblast activity reflected by 
constant osteocalcin levels suggesting that the high casein diet would 
eventually cause a small net loss of bone. Indeed, elevated urinary Ca2+ was 
paralleled with Dpd levels indicating that this calcium load may at least in part 
originate from bone. However, effects of acidosis on calcium binding to 
albumin could also contribute to hypercalciuria and hypercalcemia as well as 
stimulation of intestinal calcium absorption during acidosis 60. The acidogenic 
HC diet reduced bone tissue mineral density of Rhcg-/- animals to help 
kidneys to buffer blood acidity and compensate for HC diet acid-load. The 
higher TMD found in the deeper bone layer of Rhcg-/-remains to be clarified 
but suggests that Rhcg deletion might influence bone development towards a 
higher density. Expression of Rhcg has not been reported for bone indicating 
that differences in TMD are rather the consequence of absent Rhcg function 
in other organs.  
 
 In summary, we demonstrate that the kidney responds to acidogenic 
high protein diets with increased ammoniagenesis and NH4
+ excretion and 
decipher the transport pathways contributing to this adaptive response. The 
renal ammonium transporter Rhcg is critical for the adaption and its absence 
or reduced activity in inherited or acquired kidney disease may contribute to 
metabolic acidosis, bone degradation, and eventually may fed back on the 
kidney contributing to the progression of kidney disease. 
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CONCISE METHODS 
 
Animals 
 Mice were genotyped by PCR directly on a 3 µl 25 mM NaOH ear 
biopsy digestion product. Genomic DNA was amplified using primer pairs 
specific for exon 1: forward (AGACCCCACAATGGAAAGCTATAA), Rhcg+/+ 
reverse (CAACCAGAACTCCCCAGTGTCAGA) and Rhcg-/- reverse 
(ATGGGCTGACCGCTTCCTCGTGCTTTAC)36. The products were separated 
by electrophoresis on 1 % agarose gels (mutant product: 522 bp, wild type 
product: 376 bp). Heterozygous mice were mated to generate mice of all 
genotypes. All animal experiments were conducted according to Swiss Laws 
of Animal Welfare and approved by the local Zurich Veterinary Authority 
(Kantonales Veterinäramt Zürich). 
 
Metabolic cage studies 
 All experiments were performed using age- matched male Rhcg wild 
type (Rhcg+/+), Rhcg knockout (Rhcg-/-) and Rhcg heterozygous (Rhcg+/-) 
littermate mice (3-4 month-old), housed in standard or metabolic cages 
(Tecniplast, Buguggiate, Italy). Mice were given deionized water and were fed 
a standard powdered laboratory chow ad libitum (Kliba, Kaiseraugst, 
Switzerland). Mice were allowed to adapt to metabolic cages for 2 days, then 
one 24 hrs urine sample was collected under light mineral oil in urine 
collectors to determine daily urinary parameters. Mice were then allowed to 
recover for 2 days in standard cages and were given high protein diet (50 % 
casein or 50 % soy) (Sniff Spezialdiaeten GmbH, Soest, Germany) for 9 days. 
Four 24 hrs urine samples were collected during the 9 days of high protein 
diet. Water and food intake, and urine excretion were monitored at baseline 
and during 9 days of high protein treatment. Blood was collected from the 
retroorbital plexus under isofluran anesthesia and analyzed in a Radiometer 
ABL 505 blood gas analyzer (Radiometer, Copenhagen, Denmark). Urinary 
pH was measured directly after collection using a pH microelectrode (691 pH 
meter, Metronohm). Urinary electrolytes concentrations were measured by 
flame photometry (IL943, Instruments Laboratory), titratable acid were 
measured using a DL 50 titrator (Mettler Toledo 36). Urinary NH3/NH4
+ and 
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creatinine were assessed using the Berthelot and Jaffe methods, respectively 
61-62. Urinary SO4
2- was measured by ion exchange chromatography using a 
IonPac® AS 11 analytical column on a Dionex DX-600 HPLC system (Dionex, 
Olten, Switzerland). Urinary Deoxypyridinoline (DPD) was measured with a 
DPD Enzyme Immunoassay kit (Microvue DPD EIA, Quidel Corporation, San 
Diego CA, USA) and plasma Osteocalcin using a Mouse Osteocalcin 
Immunoradiometric Assay kit (Mouse Osteocalcin IRMA Kit, Immunotopics, 
San Clemente CA, USA). Mice were anesthetized with ketamine and xylazine 
and sacrified at different time points to collect blood, kidneys, and femurs. 
Kidneys were immediately flash-frozen in liquid nitrogen and placed at -80ºC 
until further processing. Femurs were collected and stored in 70% ethanol at 
room temperature. 
 
RNA extraction and reverse transcription 
 Snap-frozen kidneys (8 or 5 half kidneys for each condition, 9 days of 
diet or 4 days of diet, respectively) were homogenized in RLT-Buffer (Qiagen, 
Basel, Switzerland) supplemented with β-mercaptoethanol to a final 
concentration of 1%. Total RNA was extracted from 200 μl aliquots of each 
homogenized sample using the RNeasy Mini Kit (Qiagen, Basel, Switzerland) 
according to the manufacturer’s instructions. Quality and concentration of the 
isolated RNA preparations were analyzed on the NanoDrop ND-1000 
spectrophotometer (Wilmington, DE, USA). Total RNA samples were stored at 
−80°C. Each RNA sample was diluted to a final concentration of 100 ng/μl, 
and cDNA was prepared using the TaqMan Reverse Transcriptase Reagent 
Kit containing 10X RT buffer, MgCl2, random hexamers, dNTPs, RNase 
inhibitors and Multiscribe reverse transcription  enzyme (Applied 
Biosystems/Roche; Forster City, CA, USA). Reverse transcription was 
performed with the Biometra TGradient thermocycler (Goettingen, Germany), 
with thermocycling conditions set at 25ºC for 10 min, 48ºC for 30 min, and 
95ºC for 5 min. 
 
Real-time semi-quantitative PCR 
 Relative mRNA expression was determined using semi-quantitative 
Real-Time RT-PCR using the Applied Biosystems 7500 Fast Real-Time PCR 
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system. Thermocycling conditions consisted of: denaturation (95°C ;10 min) 
followed by 40 cycles of denaturation at 95°C for 15s and 
annealing/elongation (60°C; 60s) with auto ramp time. All reactions were run 
in triplicate. Forward and reverse primer and probe concentrations were 25 
μM and 5 μM, respectively. TaqMan Universal PCR master mix 2X (Applied 
Biosystems/Roche) was used as the Taq polymerase. Primers and probes for 
SNAT3, phosphate-dependent glutaminase (PDG), NHE3, cytosolic 
phosphoenolpyruvate carboxykinase (PEPCK), NKCC2, and Hypoxanthine-
guaninephosphoribosyltransferase (HPRT) were generated using Primer 
Express software from Applied Biosystems and synthesized at Microsynth 
(Balgach, Switzerland) as described previously36, 63. Probes were generated 
with the reporter dye FAM at the 5’ end and TAMRA at the 3’ end.Reactions 
were run in triplicates including a negative control (without Multiscribe reverse 
transcription enzyme). The cycle threshold (Ct) values obtained were 
ultimately compared to Ct values of the endogenous  gene HPRT. Relative 
mRNA expression ratios were calculated as: R = 2[Ct(HPRT/Ct(gene of interest)], where 
Ct represents the cycle number at threshold 0.02.  
 
Immunoblotting 
 Crude total membrane proteins or cytosolic fractions were obtained 
from kidneys homogenized in 250 mM sucrose, 10 mM Tris-HCl, pH 7.5, and 
in the presence of protease inhibitors (complete ULRA tablets, Roche, 
Rotkreuz, Switzerland). Fourty micrograms of crude membrane proteins or 
cytosolic proteins were solubilized in loading buffer containing DTT (2 M) and 
separated on 5 to 10% polyacrylamide gels. For immunoblotting, proteins 
were transferred electrophoretically to polyvinylidene fluoride membranes 
(Immobilon-P, Millipore Corp., Bedford, MA, USA). After blocking with 5 % 
milk powder in Tris-buffered saline-0.1% Tween-20 for 60 min, membranes 
were incubated with rabbit polyclonal anti-SNAT3 (diluted 1:1000)63, anti-PDG 
(diluted 1:5000, kindly provided by Dr. N. Curthoys, Univ. of Colorado), anti-
PEPCK (diluted 1:5000, Cayman Chemical, Ann Arbor, MI, USA), rabbit 
polyclonal anti-NKCC2 and anti-AQP2 (diluted 1:5,000, kindly provided by J. 
Loffing, Institute of Anatomy, Univ. of Zurich), rabbit anti pSer256-AQP2 
1:3000 (kindly provided by Dr. Soren Nielsen, University of Aarhus, Denmark), 
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rabbit polyclonal anti-NHE3 (StressMarq Biosciences Inc., Victoria, BC, 
Canada) and mouse monoclonal anti-β-actin antibody (Sigma, St. Louis, MO; 
1:20,000) overnight at 4°C. After washing and blocking with 5 % milk powder 
for 60 min, membranes were then incubated for 2 h at room temperature with 
secondary goat anti-rabbit 1:5000 or donkey anti-mouse antibodies 1:10,000 
linked to alkaline phosphatase (AP) (Promega, Madison, WI, USA) or 
horseradish peroxydase (HRP) (Promega, Madison, WI, USA), respectively. 
The protein signal was detected with the appropriate substrate (CDP-Star, 
Roche, Rotkreuz, Switzerland for AP, Millipore Corp, Bedford, MA, USA for 
HRP) using the Las-4000 image analyzer system (Fujifilm Life Science, USA). 
All images were analyzed with Advanced Image Data Analyzer AIDA 
(Raytest, Straubenhardt, Germany) to calculate the protein of interest/β-actin 
ratio. 
 
Measurement of renal ammonium content 
 Renal tissue ammonium content was measured by an enzymatic 
technique (SIGMA, Ammonia Assay Kit) as previously described 36. Mice 
were anesthetized, kidneys removed, and immediately frozen in liquid 
nitrogen. Kidneys were then sliced frozen to yield a column of tissue, which 
extended from the cortex to the tip of the papilla. Sections were cut along the 
cortico-medullary axis to yield 3 slices: cortex, outer medulla, and inner 
medulla. Two kidneys were pooled for each sample. Tissue slices were then 
homogenized in 300 µl of ice cold 7 % trichloroacetic acid, and the solution 
was centrifuged. The supernatant was drawn off and the pH of a 250 µl 
sample was adjusted to near neutral by the addition of 12 µl of 10 mM 
Na2HPO4 in 9 N NaOH. A 200 µl sample of buffered supernatant was then 
analyzed for ammonium concentration. The pellet was re-suspended in 1 N 
NaOH, shaken overnight, and analyzed for total protein concentration using 
the Biorad protein assay (Biorad Hercules, CA, USA). 
 
Micro-CT imaging and quantitative analysis 
 Whole femurs of n = 5 Rhcg+/+ and n = 5 Rhcg-/-were scanned with a 
desktop micro-CT (μCT40, Scanco Medical, Switzerland) operated at 55 kVp 
and 145 µA. The samples were scanned with the long axis perpendicular to 
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the beam direction and using an integration time of 300 ms and a frame 
averaging of 3, resulting in a total scanning time of approximately 5.1 hours 
per sample. Before image reconstruction, a voltage-specific third-order 
polynomial correction 52 provided by the manufacturer was applied to 
minimize the influence of beam hardening. The reconstructed scans had a 
nominal isotropic resolution of 10 μm. A three-dimensional Gaussian filter 
(sigma 0.8, support 1) was applied to reduce the noise present in the images 
and the grey levels of the scans were then transformed into tissue mineral 
density (TMD) by using the manufacturer calibration record based on a 
phantom of 1200 mg HA/cm3 64. The micro-CT scanner was calibrated weekly 
for mineral equivalent value, and monthly for determining in-plane spatial 
resolution. All measurements and analyses were performed according to the 
guidelines for assessment of bone microstructure in rodents using micro-CT 
65. Standard three-dimensional morphometric parameters were computed for 
full, cortical and trabecular bone as described elsewhere 66. TMD was 
evaluated in the cortical bone compartment having a size of 30% of the total 
femoral lengthby averaging the TMD values in different layers having the 
same distance to the bone surface, accordingly to a recently developed layer 
analysis 67. Specifically, we analyzed the TMD in layer 2 (i.e., close to the 
bone periosteal surface and hence affected by diet) and in layer 12 (i.e. far 
from the bone surface and thus not affected by diet). 
 
Statistics 
 Statistical comparisons were tested by ANOVA (1 way, Newman-Keuls 
multiple comparison test) and unpaired t-test using Graphpad Prism 
(GraphPad Software). P values < 0.05 were considered as statistically 
significant. 
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FIGURE LEGENDS 
 
Table 1 
Body weight, food intake, and urinary values of Rhcg+/+, Rhcg+/-, and Rhcg-/-
mice during 9 days high casein (HC) protein loading (n = 8 mice for each 
group). ND not determined, # P ≤ 0.05 significantly different from same 
genotype under control conditions, * P ≤ 0.05 significantly different from 
Rhcg+/+ mice under same treatment conditions, ** P ≤ 0.01 significantly 
different from  Rhcg+/+ mice under same treatment conditions 
 
Figure 1. Acid-base parameters in Rhcg+/+, +/- and -/- mice during 9 days 
high casein diet 
Blood and urine data were collected in Rhcg+/+, +/- and -/- mice treated for 9 
days on high casein (HC) diet. All animals showed a transient decrease of 
blood pH (A) and bicarbonate (B). (C) Titratable acids increased on high 
casein diet. (D) All mice rapidly increased urinary NH4
+ excretion, however, 
Rhcg-/- had lower NH4
+ excretion than Rhcg+/+ during days 2 and 4 of the high 
casein diet. Values are mean ± SEM (n= 8 mice) *p ≤ 0.05 (Rhcg-/-vs Rhcg+/+), 
# P ≤ 0.05 significantly different from same genotype under control conditions 
(day 0), * P ≤ 0.05 significantly different from Rhcg+/+ mice under same 
treatment conditions and for the same time point.  
 
Figure 2. High casein diet stimulated the ammonagenic pathway 
Kidneys collected from all 3 groups of mice after 4 or 9 days HC diet were 
analyzed by RT-qPCR and immunoblotting. After 4 days HC diet 
Rhcg+/+highly increased mRNA (A) and protein (B) expression of 
SNAT3.Rhcg+/- and -/- exhibited higher SNAT3 mRNA (A) and protein (E) 
levels than Rhcg+/+. At day 9, only Rhcg-/-kept an enhanced level of SNAT3 
mRNA (A) and protein (F). 4 or 9 days HC diet augmented Rhcg+/+ PDG 
mRNA (C) or protein (D) abundance. Rhcg-/- displayed higher mRNA (C) after 
9 days HC and higher protein (H) expressions after both 4 and 9 days HC. 
Values are mean ± SEM (n= 4-8 mice) # P ≤ 0.05 significantly different from 
same genotype under control conditions (day 0), * P ≤ 0.05, ** P ≤ 0.01, *** P 
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≤ 0.001   significantly different from Rhcg+/+ mice under same treatment 
conditions and for the same time point.  
 
Figure 3. Altered medullary absorption and accumulation of ammonium 
in Rhcg deficient mice  
After 4 or 9 days HC diet treatment, Rhcg+/+, +/- and -/- mice kidneys were 
submitted to Western blot analysis and NH4
+ concentration was measured in 
dissected cortex, inner and outer medulla. Expression of NKCC2 was higher 
in Rhcg+/- and -/- than Rhcg+/+at day 4 HC diet (A) while at day 9, Rhcg-/- 
showed a reduced level (B). (C) NH4
+ concentration was similarly increased in 
Rhcg+/- and -/-mice kidney inner medulla at day 4 HC diet. (D) At day 9, Rhcg-/- 
had much lower inner medullaryNH4
+ content. Values are mean ± SEM (n= 6-
7 mice) # P ≤ 0.05 significantly different from same genotype under control 
conditions (day 0), * P ≤ 0.05, *** P ≤ 0.001   significantly different from 
Rhcg+/+ mice under same treatment conditions and for the same time point.  
 
Figure 4. High casein diet stimulates diuresis and regulates NKCC2 and 
AQP2 expression  
Protein expression levels were examined using immunoblotting and urine 
production was measured at different time points of HC diet in Rhcg+/+ and -/- 
mice. NKCC2 protein level were decreased after 4 and 9 days HC diet in 
Rhcg+/+ (A) and only after 9 days in Rhcg-/- (C) while AQP2 expression was 
reduced in Rhcg+/+ (B) and -/- (D) mice at day 9 HC diet. Rhcg-/- showed higher 
urinary excretion than Rhcg+/+ (E). Mature pSer256-AQP2 showed decreased 
abundance at day 9 in Rhcg-/- and the ratio of pSer256-AQP2 over total AQP2 
was reduced in Rhcg-/- (F). Values are mean ± SEM (n= 4-8 mice),  # P ≤ 0.05 
significantly different from same genotype under control conditions (day 0), * 
P ≤ 0.05, ** P ≤ 0.01 significantly different from Rhcg+/+ mice under same 
treatment conditions and for the same time point. 
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Figure 5. Hypercalcemia, hypercalciuria, and increased 
deoxypyridynoline (Dpd) excretion in Rhcg-/-mice 
(A) After 2 and 4 days of high casein diet, ionized Ca2+ concentration was 
higher in Rhcg-/- blood. (B) At day 4, urinary Ca2+ excretion was also 
increased in Rhcg -/-. (C) The release of the bone degradation marker 
deoxypyridinoline (Dpd) was augmented in Rhcg-/- compared to Rhcg+/+ 
following 4 and 9 days high casein diet whereas the plasma concentration of 
the bone formation maker osteocalcin was not affected by diet and genotype. 
Values are mean ± SEM (n= 5-8 mice),  # P ≤ 0.05 significantly different from 
same genotype under control conditions (day 0), * P ≤ 0.05, ** P ≤ 0.01 
significantly different from Rhcg+/+ mice under same treatment conditions and 
for the same time point. 
 
Figure 6. High casein diet reduces bone mineral density in Rhcg-/- mice 
(A) Micro-CT reconstruction of a femur with the mid-cortical region considered 
for tissue mineral density (TMD) evaluation. The inset shows the different grey 
values (top), which carry information on TMD and a cross-section (bottom) 
with layer 2 close to the periosteum (light grey) and layer 12 (dark grey). (B) 
TMD of Rhcg-/- was higher than Rhcg+/+ in the diet independent layer 12 but 
not in layer 2 which was formed during the diet. Data are represented by 
boxplots, i.e. the inner box contains 50 % of all data, the whisker bars denote 
the full range and the black line represents the median value (over all 
animals). Statistical significance was obtained with 2way ANOVA with 
Bonferroni’s multiple comparisons test, ** P ≤ 0.01 significantly different from 
wild-type mice under same treatment conditions and for the same time point, 
NS = not significant. 
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Table 1. Body weight, food intake, and urinary values of Rhcg+/+, Rhcg+/-, and Rhcg-/-mice during 9 days high casein (HC) protein 
loading 
 
 Basal status 2 days HC diet 4 days HC diet 9 days HC diet 
 Rhcg
+/+
 Rhcg
+/-
 Rhcg
-/-
 Rhcg
+/+
 Rhcg
+/-
 Rhcg
-/-
 Rhcg
+/+
 Rhcg
+/-
 Rhcg
-/-
 Rhcg
+/+
 Rhcg
+/-
 Rhcg
-/-
 
 (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) 
Body weight (g) 
 
28.2 ± 0.6 29.7 ± 0.4 27.0 ± 0.8 28.0 ± 0.5 29.5 ± 0.7 26.0 ± 0.9 27.6 ± 0.6 29.0 ± 0.7 25.7 ± 0.9 27.8 ± 0.4 27.3 ± 0.9 25.9 ± 0.9 
 
Food intake  
(g/24hrs/body weight) 
0.14 ±  
0.02 
0.14 ±  
0.03 
0.15 ±  
0.02 
0.10 ± 
0.02# 
0.08 ± 
0.04# 
0.10 ± 
0.04# 
0.10 ± 
0.02# 
0.10 ± 
0.03# 
0.10 ± 
0.02# 
0.12 ± 
0.02# 
0.10 ± 
0.05# 
0.10 ± 
0.02# 
 
Water intake 
(g/24hrs/body weight) 
0.16 ±  
0.01 
0.14 ±  
0.01 
0.15 ±  
0.01 
0.24 ± 
0.03# 
0.21 ± 
0.02# 
0.21 ± 
0.02# 
0.22 ± 
0.03# 
0.23 ± 
0.02# 
0.26 ± 
0.03# 
0.25 ± 
0.03# 
0.24 ± 
0.03# 
0.26 ± 
0.03# 
 
Urine values             
 
Volume (ml/24h) 
 
1.89 ±  
0.32 
1.91 ±  
0.18 
1.74 ±  
0.19 
 
4.51 ± 
0.44# 
4.34 ± 
0.29# 
5.20 ± 
0.37# 
4.24 ± 
0.50# 
4.38 ± 
0.38# 
5.523± 
0.55# 
4.52 ± 
0.17# 
4.36 ± 
0.24# 
5.65 ± 
0.30**# 
Urinary pH 
 
5.94 ± 0.08 5.97 ± 0.04 6.03 ± 0.06 6.0 ± 0.04 5.94 ± 0.03 5.87 ± 0.04 5.97± 0.04 6.03 ± 0.05 5.89 ± 0.04 5.91 ± 0.04 5.85 ± 0.04 5.86 ± 0.07 
 
NH4
+
/Urine volume (mmol/24h) 
 
0.028 ± 
0.01 
0.028 ±  
0.01 
0.027 ± 
0.01 
0.26 ± 
0.08# 
0.24.0 ± 
0.07# 
0.16 ± 
0.04*# 
0.29 ± 
0.08# 
0.24 ± 
0.07# 
0.17 ± 
0.05***# 
0.28 ± 
0.08# 
0.28 ± 
0.05# 
0.29 ± 
0.08# 
 
TA/ Urine volume (mmol/24h) 
 
0.08 ±  
0.06 
0.09 ±  
0.03 
0.07 ±  
0.03 
0.22 ± 
0.09# 
0.25 ± 
0.05# 
0.22 ± 
0.06# 
0.20 ± 
0.08# 
0.23 ± 
0.06# 
0.23 ± 
0.08# 
0.24 ± 
0.07# 
0.28 ± 
0.06# 
0.27 ± 
0.05# 
 
Ca
2+
/ Urine volume (μmol/24h) 
 
1.5 ± 
0.1 
1.6 ± 
0.1 
1.2 ± 
0.1 
3.3 ±  
0.1# 
 
3.2 ±  
0.7# 
 
6.5 ±  
0.2**# 
5.4 ± 
0.3# 
5.5 ± 
0.2# 
10.2 ±  
0.4*# 
4.1 ±  
0.4 
6.8 ±  
0.2# 
8.1 ±  
0.4# 
 
Dpd/Urine volume (nmol/24h) 
 
0.076 ± 
0.04 
n=6 ND 
0.073 ± 
0.02 
n=6 ND ND ND 
0.100 ± 
0.07 
n=6 ND 
0.211 ± 
0.01*# 
n=6 
0.093 ± 
0.02 
n=6 ND 
0.149 ± 
0.05*# 
n=6 
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Supplementary table 1 
Blood values of Rhcg+/+, Rhcg+/-, and Rhcg-/-mice on normal diet and duringthe high 
casein (HC) protein loading (n = 8 mice for each group). ND notdetermined, # P ≤ 
0.05 significantly different from same genotype undercontrol conditions, * P ≤ 0.05 
significantly different from Rhcg+/+ mice undersame treatment conditions, ** P ≤ 0.01 
significantly different from Rhcg+/+miceunder same treatment conditions 
 
Supplementary table 2 
Body weight, food intake and urinary values of Rhcg+/+,Rhcg+/-, and Rhcg-/-mice 
during 9 days high soy (HS) protein loading (n = 6 mice for each group), # P ≤ 0.05 
significantly different from same genotype under control conditions 
 
Supplementary table 3 
Urinary values of Rhcg+/+,Rhcg+/-, and Rhcg-/-mice during 9 days high casein(HC) 
protein loading (n = 8 mice for each group). ND not determined, # P ≤0.05 
significantly different from same genotype under control conditions, * P ≤0.05 
significantly different from Rhcg+/+mice under same treatment conditions,** P ≤ 0.01 
significantly different from Rhcg+/+mice under same treatmentconditions 
 
Supplementary table 4 
Blood values of Rhcg+/+,Rhcg+/-, and Rhcg-/-mice on normal diet and duringthe high 
soy (HS) protein loading (n = 6 mice for each group). ND notdetermined, # P ≤ 0.05 
significantly different from same genotype undercontrol conditions 
 
Supplementary table 5 
Standard morphometric bone parameters of Rhcg+/+and Rhcg-/-mice during 9days 
high casein (HC) protein loading (n = 5 mice for each group). Nosignificant 
differences were detected between genotypes. 
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Supplementary figure 1 
Nine days high soy diet does not acid load Rhcg+/+,Rhcg+/-, and Rhcg-/-  mice. 
Blood and urine data were collected from Rhcg+/+,Rhcg+/-, and Rhcg-/-mice treated for 
9days with high soy (HS) diet. HS did not induce an acid load as indicated byblood 
pH (A) and bicarbonate (B), urinary titratable acidity (C) or NH4
+excretion (D). Values 
are mean ± SEM (n = 6 mice) # P ≤ 0.05 significantlydifferent from same genotype 
under control conditions (day 0). 
 
Supplementary figure 2 
Rhcg mRNA expression is altered by HC diet while Rhbg mRNA level 
remainsunchanged. 
Rhcg and Rhbg mRNA expression was measured by RT-qPCR in kidneysfrom 
Rhcg+/+and Rhcg-/-mice during 0, 4 and 9 days HC diet. Four days HCdiet induced a 
transient increase of Rhcg mRNA expression (A). mRNA levelsof RhBG remained 
unchanged in Rhcg+/+and Rhcg-/-during 0, 4 and 9 daysHC. Values are mean ± SEM 
(n= 6 mice), # P ≤ 0.05 significantly differentfrom same genotype under control 
conditions (day 0). 
 
Supplementary figure 3 
mRNA and protein expression of PEPCK and NHE3 proximal tubuleproteins 
areunchanged by HC diet. 
Immunoblotting of Rhcg+/+ kidney protein extracts collected during HC diet didnot 
show any changes in PEPCK (A) or NHE3 (B) expression in response tothe 
treatment. PEPCK (C) and NHE3 (D) mRNA levels assessed by RT-qPCRdid not 
display either differences comparing Rhcg+/+,Rhcg+/-, and Rhcg-/-after 9 days 
HC.Similarly, PEPCK and NHE3 protein levels were identical comparing all 3groups 
of mice 4 or 9 days-HC diet fed. Values are mean ± SEM (n= 8 mice),p ≥ 0.05 
 
Supplementary figure 4 
High soy protein diet does not alter NKKC2 and AQP2 protein abundance in 
Rhcg+/+mice. 
The expression of NKCC2 (A) and AQP2 (B) was measured by 
immunoblotting in kidneys from Rhcg+/+ mice and remained similar between 
days 0 and 9 of high soy diet. Values are mean ± SEM (n = 8 mice). 
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Suppplementary Table 1. Blood values of Rhcg+/+, Rhcg+/-, and Rhcg-/ mice on 
normal diet and during the high casein (HC) protein loading 
 
 
  
Basal status          
 
2 days HC diet 
 
4 days HC 
diet 
 9 days HC diet 
  Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- 
  (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=5) (n=5) (n=8) (n=8) (n=8) 
 
pH 
7.35 ± 
0.01 
7.33 ± 
0.01 
7.34 ± 
0.01 
7.26 ± 
0.03# 
7.27 ± 
0.01# 
7.28 ± 
0.03# 
7.36 ± 
0.01 
7.34 ± 
0.01 
7.37 ± 
0.02 
7.35 ± 
0.01 
7.34 ± 
0.02 
pCO2 
(mmHg) 
 
37.4 ± 
1.1 
39.5 ± 
1.0 
37.5 ± 
0.8 
39.1 ± 
1.4 
38.4 ± 
1.1 
36.9 ± 
1.1 
37.1 ± 
1.1 
39.5 ± 
1.8 
40.2 ± 
1.1 
38.5 ± 
1.2 
38.9 ± 
1.4 
HCO3
- 
(mM) 
 
20.1 ± 
0.4 
19.0 ± 
0.3 
19.7 ± 
0.4 
17.2 ± 
1.4# 
16.9 ± 
0.5# 
15.5 ± 
1.5# 
22.2 ± 
0.4 
20.8 ± 
0.9 
22.5 ± 
0.8 
20.7 ± 
0.7 
20.1 ± 
1.1 
Hct (%) 
 
49.9 ± 
0.2 
49.4  ± 
0.6 
50.2 ± 
1.0 
51.1 ± 
0.7 
50.7 ± 
0.7 
52.6 ± 
0.7 
49.6 ± 
0.2 
50.6 ± 
0.6 
53.5 ± 
0.8# 
52.2 ± 
0.7# 
55.8 ± 
0.6# 
Na
+
 (mM) 
 
146.5 ± 
0.5 
146.9 ± 
0.4 
145.5 ± 
0.4 
147.5 ± 
0.4 
148.7 ± 
0.4 
147.6 ± 
0.7 
144.8 ± 
0.6 
145.4 ± 
0.5 
147.8 ± 
0.5 
148.5 ± 
0.5 
146.5 ± 
0.4 
Cl
-
 (mM) 
 
112.9 ± 
0.4 
114.1 ± 
0.6 
111.9 ± 
0.5 
117.7 ± 
1.0# 
118.3 ± 
0.9# 
121.4 ± 
1.2# 
110.4 ± 
1.3 
112.0 ± 
0.8 
116.8 ± 
1.2# 
116.3 ± 
1.0# 
119 ± 
1.7# 
Ionized 
Ca
2+
(mM) 
 
1.24 ± 
0.006 
1.26 ± 
0.009 
1.24 ± 
0.002 
1.33 ± 
0.005# 
1.30 ± 
0.004# 
1.39 ± 
0.01**# 
1.25±  
0.008 
1.30 ± 
0.009*# 
1.28 ± 
0.009 
1.29 ± 
0.001 
1.25 ± 
0.006 
K
+
 (mM) 
 
4.6 ± 
1.2 
4.4  ± 
1.1 
4.5 ± 
1.1 
4.8 ± 
0.2 
4.6 ± 
0.2 
4.1 ± 
0.1 
4.9 ± 
0.2 
4.7 ± 
0.7 
4.6 ± 
0.1 
4.6 ± 
0.2 
4.3 ± 
0.2 
Glucose 
(mM) 
 
10.6 ± 
0.6 
10.7 ± 
0.5 
11.7  ± 
0.5 
8.0 ± 
1.1# 
8.9 ± 
0.5# 
9.4 ± 
0.7# 
11.9 ± 
0.4 
12.1 ± 
0.5 
10.0 ± 
0.9 
10.2 ± 
0.6 
12.2 ± 
0.9 
Lactate 
(mM) 
 
3.6 ± 
0.3 
3.6 ± 
0.2 
3.9 ± 
0.7 
3.8 ± 
0.4 
3.3 ± 
0.3 
3.3 ± 
0.3 
3.5 ± 
0.2 
3.0 ± 
0.4 
2.4 ± 
0.2# 
2.6 ± 
0.2# 
2.9 ± 
0.3# 
Osteocalcin 
(ng/mL) 
 
152.5 ± 
20.4 ND 
135.7 ± 
20.0 ND ND ND 
144.8 ± 
 10.0 
108.1 ± 
18.7 
132.1 ± 
15.1 ND 
113.9 ± 
10.4 
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Supplementary table 2. Body weight, food intake and urinary values of Rhcg+/+, 
Rhcg+/-, and Rhcg-/- mice during 9 days high soy (HS) protein loading. 
 
 
 Basal status 2 days HS diet 4 days HS diet 9 days HS diet 
 Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- 
 (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) III.1.1.1.1.1.1.1.1 (n=6) (n=6) (n=6) 
Body weight 
(g) 
 
28.5 ± 
1.6 
 
26.0 ± 
1.1 
 
27.2 ± 
1.4 
 
27.6 ± 
1.5 
 
25.2 ± 
1.1 
 
25.6 ± 
1.3 
 
26.8 ± 
1.3 
 
25.0 ± 
1.1 
 
25.6 ± 
1.3 
 
25.8 ± 
0.9 
 
25.0 ± 
1.2 
 
25.2 ± 
1.1 
 
Food intake  
(g/24hrs/body 
weight) 
0.12 ± 
0.01 
0.12 ± 
0.01 
0.11 ± 
0.02 
0.12 ± 
0.02 
0.12 ± 
0.01 
0.13 ± 
0.01 
0.10 ± 
0.01 
0.12 ± 
0.01 
0.11 ± 
0.01 
0.14 ± 
0.01 
0.13 ± 
0.01 
0.13 ± 
0.01 
 
Water 
intake 
(g/24hrs/bo
dy weight) 
0.15 ± 
0.02 
0.16 ± 
0.01 
0.16 ± 
0.02 
0.22 ± 
0.03# 
0.26 ± 
0.02# 
0.23 ± 
0.02# 
0.23 ± 
0.01# 
0.23 ± 
0.02# 
0.25 ± 
0.03# 
0.27 ± 
0.03# 
0.28 ± 
0.02# 
0.27 ± 
0.03# 
 
Urine 
values 
            
Volume 
(ml/24 h) 
 
1.84 ± 
0.22 
 
1.83 ± 
0.27 
 
1.79 ± 
0.20 
 
2.95 ± 
0.38# 
 
2.87 ± 
0.35# 
 
3.37 ± 
0.56# 
 
2.58 ± 
0.18# 
 
2.03 ± 
0.26# 
 
2.50 ± 
0.39# 
 
3.24 ± 
0.33# 
 
2.53 ± 
0.35# 
 
3.36 ± 
0.30# 
 
Creatinine 
excretion  
(µmol/24h) 
10.18± 
0.53 
11.52 
± 1.18 
10.70± 
1.57 
7.92 ± 
1.47# 
7.15 ± 
0.77# 
7.51 ± 
0.50# 
5.98 ± 
0.71# 
4.76 ± 
0.59# 
5.34 ± 
0.49# 
6.92 ± 
1.19# 
5.71 ± 
1.12# 
7.11 ± 
1.08# 
Urinary pH 
5.91 ± 
0.08 
5.63 ± 
0.07 
5.70 ± 
0.11 
6.83 ± 
0.18# 
7.06 ± 
0.23# 
6.95 ± 
0.17# 
7.09 ± 
0.14# 
7.26 ± 
0.09# 
7.29 ± 
0.11# 
7.11 ± 
0.27# 
7.15 ± 
0.13# 
6.99 ± 
0.17# 
 
NH4
+
/24h 
(µmol/24h) 
46.9 ± 
4.0 
53.1 ± 
4.3 
46.2 ± 
3.9 
14.8 ± 
1.5# 
12.9 ± 
1.2# 
13.7 ± 
2.0# 
10.9 ± 
2.9# 
12.0 ± 
1.6# 
12.9 ± 
1.2# 
17.1 ± 
1.8# 
15.3 ± 
1.7# 
15.1 ± 
1.9# 
 
TA/24h 
(µmol/24h) 
211.1 
± 11.5 
182.8 
± 11.8 
197.3 
± 12.1 
19.1 ± 
1.8# 
20.7 ± 
1.9# 
23.3 ± 
1.5# 
27.1 ± 
1.7# 
23.22 
± 1.8# 
24.1 ± 
1.9# 
23.3 ± 
1.6# 
28.4 ± 
1.6# 
25.2 ± 
1.5# 
 
PO4
2-
/Crea  
(mM/mM) 
5.0 ± 
0.8 
6.0 ± 
0.4 
5.8 ± 
0.6 
2.8 ± 
0.2# 
2.1 ± 
0.3# 
1.9 ± 
0.3# 
2.8 ± 
1.8# 
2.8 ± 
0.4# 
2.6 ± 
0.3# 
3.0 ± 
0.3# 
3.8 ± 
0.7# 
3.7 ± 
0.6# 
 
Urea/24h 
 (µmol/24h) 
2.31 ± 
0.52 
2.64 ± 
0.37 
2.86 ± 
0.78 
6.90 ± 
0.35# 
7.33 ± 
0.98# 
7.02 ± 
0.78# 
6.18 ± 
0.65# 
7.51 ± 
0.87# 
6.97 ± 
0.83# 
8.21 ± 
0.62# 
7.69 ± 
0.47# 
8.02 ± 
0.39# 
 
Ca
2+
/24h 
(µmol/24h) 
2.16 ± 
0.02 
2.21 ± 
0.03 
2.33 ± 
0.07 
1.99 ± 
0.05 
2.09 ± 
0.07 
2.01 ± 
0.02 
2.14 ± 
0.07 
2.10 ± 
0.03 
2.16 ± 
0.04 
1.87 ± 
0.06 
1.98 ± 
0.08 
2.03 ± 
0.07 
 
Na
+
/Crea 
(mM/mM) 
17.5± 
1.5 
13.5± 
2.9 
11.6 ± 
3.5 
60.5 ± 
13.2# 
62.0 ± 
7.0# 
50.7 ± 
8.3# 
80.9 ± 
9.8# 
81.4 ± 
9.3# 
85.8 ± 
9.7# 
74.0 ± 
9.0# 
91.0 ± 
7.0# 
81.8 ± 
11.3# 
 
Cl
-
/Crea  
(mM/mM) 
41.6 ± 
4.0 
41.5 ± 
1.9 
33.0 ± 
4.1 
61.5 ± 
17.2# 
58.5 ± 
5.7# 
62.5 ± 
2.5# 
68.0 ± 
8.7# 
73.9 ± 
5.3# 
74.0 ± 
8.9# 
58.4 ± 
7.5# 
76.2 ± 
10.1# 
76.7 ± 
9.0# 
 
K
+
/Crea 
 (mM/mM) 
58.2 ± 
5.4 
62.7± 
90.6 
50.9 ± 
6.2 
73.4 ± 
19.4# 
75.5 ± 
6.3# 
71.8 ± 
5.3# 
82.6 ± 
10.2# 
81.9 ± 
6.8# 
85.2 ± 
6.9# 
76.7 ± 
10.9# 
93.4 ± 
11.0# 
81.9 ± 
11.9# 
 
SO4
2
/24 h 
(µmol/24 h) 
0.26± 
0.4 
n=6 
0.21± 
0.2 
n=5 
0.24.0 
± 0.7 
n=6 
ND ND ND ND ND ND 
0.30 ± 
0.3 
n=6 
0.27 ± 
0.6 
n=5 
0.28 ± 
0.3 
n=6 
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Supplementary table 3. Urinary values of Rhcg+/+, Rhcg+/-, and Rhcg-/-mice during 9 
days high casein (HC) protein loading 
 
 
 Basal status 2 days HC diet 4 days HC diet 9 days HC diet 
 
Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- Rhcg+/+ Rhcg+/- Rhcg-/- 
 
(n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) (n=8) 
 
Creatinine 
excretion 
(µmol/24h) 
6.53 ± 
0.38 
6.81 ± 
0.99 
6.89 ± 
0.85 
6.45 ± 
0.70 
6.96 ± 
0.73 
6.59 ± 
0.41 
6.04 ± 
0.60 
6.56 ± 
0.21 
6.22 ± 
0.81 
6.57 ± 
0.52 
6.48 ± 
0.33 
6.85 ± 
0.72 
 
PO4
2-
/Crea 
(mM/mM) 
8.0 
± 
1.0 
7.4 
± 
1.1 
6.2 
± 
1.0 
17.7 
±  
1.6# 
16.7  
± 
 0.9# 
18.2 
 ±  
3.1# 
18.0 
 ±  
1.8# 
13.9  
± 
 0.9# 
20.4 
 ±  
1.3# 
20.1 
±  
1.9# 
20.5 
 ± 
 0.9# 
18.8  
±  
3.3# 
 
Urea/Urine 
volume 
(µmol/24h) 
2.40 ± 
0.17 
2.60 ± 
0.28 
2.81 ± 
0.26 
7.79 ± 
0.75# 
7.81 ± 
0.61# 
7.89 ± 
0.63# 
6.37 ± 
0.65# 
8.27 ± 
0.74# 
8.12± 
0.99# 
6.89 ± 
0.58# 
9.48 ± 
0.67# 
10.84± 
0.40*# 
 
Na
+
/Crea 
(mM/mM) 
22.3 ± 
3.7 
28.0 ± 
3.0 
35.6 ± 
8.4 
35.2 ± 
4.5 
36.1± 
49 
42.5 ± 
7.2 
34.3 ± 
4.0 
25.9  ± 
3.5 
28.1 ± 
2.1 
35.2 ± 
6.1 
37.9  ± 
3.2 
29.8 ± 
3.5 
 
Cl
-
/Crea 
(mM/mM) 
54.7 ± 
6.9 
67.6 ± 
6.7 
63.6 ± 
10.6 
59.6 ± 
6.1 
61.0 ± 
7.0 
67.2 ± 
10.9 
58.5 ± 
5.6 
60.0 ± 
3.2 
50.4 ± 
4.1 
60.4 ± 
7.7 
68.5 ± 
4.5 
58.1 ± 
6.4 
 
K
+
/Crea 
(mM/mM) 
98.5 ± 
7.3 
92.3 ± 
9.0 
96.6 ± 
14.2 
106.9 
± 9.8 
117.0 
± 10.6 
133 ± 
20.6 
104.4 
± 
8.9 
89.7 ± 
8.2 
125.3 
± 14.4 
113.5 
± 12.5 
122.6 
± 
6.4 
123.2 
± 11.9 
 
SO4
2-
/Urine 
volume 
(µmol/24h) 
      0.22 ± 
     0.9 
0.18 ± 
0.2 
0.23 ± 
0.4 
0.43 ± 
0.8# 
0.49 ± 
0.5# 
0.53 ± 
0.1# 
0.51 ± 
0.6# 
0.53 ± 
0.5# 
0.47 ± 
0.7# 
0.52 ± 
0.8# 
0.58 ± 
0.9# 
0.56 ± 
0.7# 
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Supplementary table 4. Blood values of Rhcg+/+, Rhcg+/-, and Rhcg-/- mice on 
normal diet and during the high soy (HS) protein loading. 
 
 
  Basal status 2 days HS diet 9 days HS diet 
  Rhcg
+/+
 Rhcg
+/-
 Rhcg
-/-
 Rhcg
+/+
 Rhcg
+/-
 Rhcg
-/-
 Rhcg
+/+
 Rhcg
+/-
 Rhcg
-/-
 
  (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) (n=6) 
pH 
7.36 ± 
0.004 
7.37 ± 
0.004 
7.36 ± 
0.003 
7.37 ± 
0.02 
7.39 ± 
0.02 
7.37 ± 
0.01 
7.37 ± 
0.02 
7.38 ± 
0.02 
7.35 ± 
0.01 
pCO2 (mmHg) 
 
38.8 ± 0.8 38.9 ± 0.2 38.2 ± 0.5 38.1 ± 1.1 39.2 ± 0.8 39.5 ± 1.9 39.1± 1.7 
39.7 ± 
1.5 
39.9 ± 
1.3 
HCO3
- 
(mM) 
 
21.1 ± 0.9 21.9 ± 0.2 21.5 ± 0.2 23.1 ± 1.4 24 ± 0.8 23.1 ± 0.9 
22.6 ± 
0.8 
23.8 ± 
0.3 
23.2 ± 
0.3 
Hct (%) 
 
49.4 ± 0.2 
49.4  ± 
0.4 49.0 ± 0.5 49.2 ± 0.7 49.5 ± 0.8 48.8 ± 1.1 
49.3 ± 
0.6 
49.2 ± 
0.8 
49.1 ± 
0.9 
Na
+
 (mM) 
 
147.5 ± 
0.5 
149.3 ± 
0.8 
149.8 ± 
0.4 148 ± 0.4 
148.4 ± 
0.5 
148.7 ± 
0.9 
147.5 ± 
0.5 
147.2 ± 
0.5 
148.3 ± 
0.6 
Cl
-
 (mM) 
 
115.0 ± 
0.1 
114.3 ± 
0.4 
115.1 ± 
0.6 
114.0± 
0.9 
113.6 ± 
0.4 
113.8 ± 
2.0 
111.1 ± 
0.1# 
112.0 ± 
0.5# 
111.5 ± 
0.9# 
Ionized 
Ca
2+
(mM) 
 
1.30 ± 
0.005 
1.27 ± 
0.008 
1.30 ± 
0.005 
1.29 ± 
0.001 
1.26 ± 
0.001 
1.25 ± 
0.002 
1.27 ± 
0.04 
1.28 ± 
0.01 
1.23 ± 
0.01# 
K
+
 (mM) 
 
5.2 ± 0.3 5.0  ± 0.2 5.2 ± 0.1 5.1 ± 0.5 5.1 ± 0.2 5.3 ± 0.3 5.3 ± 0.2 5.2 ± 0.3 5.2 ± 0.2 
Glucose (mM) 
 
12.1 ± 0.2 12.3 ± 0.4 
12.0  ± 
0.3 11.8 ± 0.4 11.2 ± 1.0 12.7 ± 1.2 
12.0 ± 
0.9 
11.9 ± 
1.0 
11.8 ± 
1.5 
Lactate (mM) 
 
4.7 ± 0.1 4.3 ± 0.3 4.4 ± 0.5 3.5 ± 1.3 3.7 ± 0.3 4.1 ± 0.7 3.4 ± 0.6 3.5 ± 0.2 3.3 ± 0.7 
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Supplementary table 5. Standard morphometric parameters from Rhcg+/+ and Rhcg 
during 9 days high casein protein loading 
 
 
 Rhcg+/+ Rhcg-/- 
 (n=5) (n=5) 
Trabecular compartment 
Bone volume fraction (%) 16.32 ± 1.56 15.27 ± 0.78 
Trabecular number (1/mm) 3.79 ± 0.47 3.38 ± 0.31 
Trabecular thickness (mm) 0.060 ± 0.003 0.062 ± 0.003 
Trabecular separation (mm) 0.277 ± 0.098 0.306 ± 0.037 
Cortical compartment 
Total cross-sectional area inside the 
periosteal envelope (mm2) 
1.000 ± 0.046 1.076 ± 0.046 
Cortical bone area (mm2) 0.954 ± 0.045 
 
1.029 ± 0.045 
Cortical area fraction (mm3) 0.954 ± 0.001 0.956 ± 0.001 
Average cortical thickness (mm) 0.237 ± 0.007 0.241 ± 0.008 
Full bone 
Apparent volume density (%) 57.44 ± 0.96 57.66 ± 0.99 
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IV  The ammonia transporter RhCG modulates 
vacuolar H
+
-ATPase function in renal intercalated 
cells 
 
Own contribution to the publication: 
 
 All mRNA analysis performed on Rhcg+/+ and -/- mice receiving 2d HCl diet 
acid-load presented in Figure 2 were carried out. 
 In Figure 3, all protein expression levels measured on Rhcg+/+ and -/- mice 
were realized.  
 Similarly, the intracellular pH measurements on HEK-RhCG and HEK-WT 
cells represented in Figure 5A were performed and from this experiment, the H+ 
fluxes in HEK-RhCG and HEK-WT displayedin Figure 5B were calculated. 
 Finally, mRNA expression levels of all genes measured in HEK-RhCG and 
HEK-WT were assessed and are showed in Figure 6. 
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Background: Urinary ammonium excretion is 
chiefly achieved by the ammonia transporter 
RhCG and vacuolar H
+
-ATPases, both 
expressed in the renal collecting duct. Rhcg 
knockout mice have more alkaline urine than 
wildtype control. 
Results: The activity of vacuolar H
+
-ATPases 
is decreased in kidney intercalated cells of 
Rhcg knockout mice with similar subcellular 
localization and altered abundance of some 
isoforms. Overexpression of Rhcg stimulates 
H
+
-ATPase activity in vitro. Genetic 
impairment of vacuolar H
+
-ATPases does not 
modify NH3 transport in intercalated cells of 
kidney. 
Conclusion: Rhcg may modify the activity of 
vacuolar H
+
-ATPases in intercalated cells of 
kidneys. 
Significance: Delineating the precise 
molecular mechanisms of urinary ammonium 
excretion and acidification by intercalated cells 
of the collecting duct in kidney. 
 
ABSTRACT 
 Ammonium (NH4
+
) is excreted into 
urine along the collecting duct (CDs) of 
kidneys representing the predominant 
mechanism of removing acid into urine. 
This process is dependent on the 
concomitant secretion of ammonia (NH3) by 
the NH3 transporter RhCG and protons(H
+
) 
by vacuolar-type H
+
-ATPases. Mice lacking 
Rhcg excrete more alkaline urine despite the 
lack of the NH3/NH4
+
 buffer indicating 
impaired urinary acidification. Here, we 
demonstrated in microperfused cortical 
collecting ducts (CCD) from Rhcg
-/-
mice 
that H
+
-ATPase activity is reduced by 89%. 
Electron microscopy with immuno-gold 
detection of the H
+
-ATPase A subunit 
demonstrated similar localization and 
density of staining. Moreover, expression 
ofthe a1, a4, and E2 H
+
-ATPase subunits 
was similar in the renal medulla of Rhcg
+/+
 
and Rhcg
-/-
 mice whereas the B1 isoform 
was enhanced and the B2 isoform reduced. 
Inversely, overexpression of RhCG in 
HEK293 cells resulted in higher H
+ 
secretion 
and increased B1 subunit mRNA 
(ATP6V1B1) expression. To further examine 
the functional interaction between RhCG 
and H
+
-ATPases, we employed the H
+
-
ATPase inhibitor concanamycin A which 
reduced H
+
-ATPase activity and RhCG 
mediated NH3 transport in intercalated 
cells, suggesting that concanamycin A either 
acts on RhCG or that H
+
-ATPase function is 
required for RhCG transport activity. Mice 
lacking the B1 H
+
-ATPase isoform had 
reduced H
+
-ATPase function without 
altering RhCG mediated NH3 transport in 
microperfused collecting ducts. Thus, RhCG 
may modulate H
+
-ATPase function, 
whereasH
+
-ATPase activity does not 
directly affect RhCG mediated NH3 
transport.  
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INTRODUCTION 
The renal collecting duct excretes acid 
into urine by parallel secretion of protons (H
+
) 
and ammonia (NH3) by V-type H
+
-ATPases 
and the ammonia transporter RhCG, 
respectively(1-3). Renal acid excretion is 
critical for maintaining normal acid-base 
homeostasis and is increased during acidosis or 
following an acid-load (2). 
Highly conserved through-out 
evolution from bacteria to humans, RhCG 
belongs to the Rhesus glycoprotein family and 
has been characterized by in vitro and ex vivo 
studies as a transporter selectively permeable 
to NH3 but not to ammonium (NH4
+
) (4-6). In 
the kidney, RhCG expression specifically 
spreads from the late distal convoluted tubule 
(DCT) to the inner medullary collecting duct 
(IMCD), on both basolateral and apical poles 
of epithelial cells (7-11). We recently showed 
that RhCG is responsible for a major part of 
NH3 transported through apical and basolateral 
membranes of the collecting duct resulting in a 
drastic reduction of transepithelial NH3 
transport in collecting ducts from totalRhcg
-/-
mice (11-12). Similarly, mice with partial 
deletion of Rhcg in different subtypes of cells 
causes a reduction in urinary ammonium 
excretion (13-14). As a consequence of this 
defect, chronically acid-loaded Rhcg
-/-
 mice 
cannot eliminate NH4
+
 into urine and develop a 
severe distal renal tubular acidosis (dRTA) 
with low blood pH and HCO3
-
 concentration 
(11-12).  
While RhCG is responsible for luminal 
NH3 secretion, the renal vacuolar H
+
-ATPase 
(H
+
-ATPase) in intercalated cells of the 
collecting duct is critical to actively secrete H
+
 
into urine (15-16). H
+
-ATPases are ubiquitous 
multi-subunits proteins composed of a 
cytosolic V1 catalytic domain, responsible for 
ATP hydrolysis and a membrane-associated V0 
domain responsible for H
+
 translocation (16-
17). In the collecting duct, vacuolar H
+
-
ATPases are localized at the luminal side of 
type-A intercalated cells and basolateral side of 
non-type Aintercalated cells. The V1 domain 
contains 8 subunits A-H including the tissue-
specific subunit isoforms B1 and B2. The B1 
isoform is highly enriched in intercalated cells 
of kidney and its genetic mutation or deletion 
cause a form of distal renal tubular acidosis 
(18-19). The V0 domain contains 6 different 
subunits, a, d, c, c', c", and e including also the 
a1, a2, a3 and a4 isoforms. Also, the a4 
isoform is highly expressed in kidney (20-21) 
and mutations in human and its deletion in 
mice are associated with renal tubular acidosis 
(22-24).  
Secretion of NH3 and protons by 
RhCG and vacuolar H
+
-ATPases may be 
coordinated since protonation of NH3 and 
subsequent trapping of NH4
+
 are critical for the 
efficient excretion of NH4
+
. The partial overlap 
of expression in type-A intercalated cells may 
allow even for a direct functional coupling or 
interaction. We have recently shown in two 
differently generated mouse models lacking 
Rhcg that urinary pH is more alkaline during 
stimulation of urinary acidification and NH4
+ 
excretion. Since Rhcg
-/-
 mice have highly 
reduced NH3 secretion, the lack of NH3 
buffering capacity would be expected to result 
in a rather more acidic urinary pH, as shown in 
another mouse model with intact Rhcg-
mediated NH3 secretion but reduced medullary 
NH4
+
 accumulation (25). Thus, we 
hypothesized that the absence of Rhcg may 
reduce proton secretion by H
+
-ATPases. 
Here we demonstrate that the lack of 
Rhcg reduces H
+
-ATPAse activity in 
microperfused collecting ducts. The absence of 
Rhcg did not alter H
+
-ATPase localization. 
Overexpression of Rhcg in HEK293 cells 
stimulated H
+
-ATPAse activity and increased 
expression of the B1 subunit. The H
+
-ATPase 
inhibitor concanamycin reduced both H
+
-
ATPase activity and Rhcg-mediated NH3 
secretion. However, in mice lacking the B1 
subunit (Atp6v1b1
-/-
) H
+
-ATPase activity was 
reduced without changing NH3 permeability, 
suggesting that H
+
-ATPase function does not 
directly affect Rhcg activity. 
 
EXPERIMENTAL PROCEDURES 
Animals - Rhcg
+/+ 
and
 -/-
mice were bred as 
described before (26). Also, Atp6v1b1
+/+
 and 
-/-
 
mice were bred as described before (27-28). 
Mice were genotyped by PCR directly on a 3 
µl 25 mM NaOH tail digestion product. 
Genomic DNA was amplified using primer 
pairs specific for Rhcg exon 1: forward 
(AGACCCCACAATGGAAAGCTATAA)and
wildtype reverse 
(CAACCAGAACTCCCCAGTGTCAGA) and 
knock-out 
reverse(ATGGGCTGACCGCTTCCTCGTGC
TTTAC) and Atp6v1b1 primer pairs specific 
for the Neo cassette: forward 
(CACGACGAGATCCTCGCCGTC) and 
  
93 
reverse (GCGCAGCTAGTGCTCGACGTTG) 
and an Atp6v1b1 3′ flanking sequence not 
included within the targeting vector: forward 
(CTGGCACTGACCACGGCTGAG) and 
reverse (CCAGCCTGTGACTGAGCCCTG). 
The products were separated by 
electrophoresis in 1% agarose gel (Rhcg 
mutant product: 522 bp, wildtype product: 376 
bp, Atp6v1b1 mutant product: 300 bp, wildtype 
product: 200bp). 
All animal experiments were performed in 
acid-loading conditions for which mice were 
given 0.2 M HCl added to powdered standard 
food for 2 days. All experiments were 
performed according to Swiss Animal Welfare 
laws and were approved by the local veterinary 
authority (Veterinäramt Zürich). 
 
In vivo experiments - All experiments were 
performed using age- and sex-matched 
Atp6v1b1 wildtype(Atp6v1b1
+/+
) and Atp6v1b1 
knockout (Atp6v1b1
-/-
) littermate mice (3-4 
month-old), housed in metabolic cages 
(Techniplast, Switzerland). Mice were given 
deionized water ad libitum and were fed with a 
standard powdered laboratory chow (Kliba, 
Augst, Switzerland). Some mice were placed 
in metabolic cages and were allowed to adapt 
to metabolic cages for 3 days.A first retro-
orbital blood sample was taken for blood gas 
analysis at baseline. Then two 24 hrs urine 
samples were collected under light mineral oil 
in the urine collector to determine daily urinary 
parameters. Mice were then allowed to recover 
for 2 weeks before given a HCl-containing diet 
(0.2 M HCl added to powdered standard food) 
in normal cages. Food, water intake, and urine 
excretion was monitored following the same 
procedures as under baseline conditions. Urine 
collections were performed on the first, second 
and fourth day of acid-loading. Retro-orbital 
blood samples were taken on the second and 
fourth day of the HCl diet.  
 
Analytic procedures - Blood pH, pCO2, and 
electrolytes were measured with a pH/blood-
gas analyzer (ABL 77 Radiometer). Urinary 
pH was measured with a pH-meter (Metrohm 
AG, Canada) and creatinine by a modified 
kinetic Jaffé colorimetric method (29). Urinary 
NH4
+
 was measured with the Berthelot 
protocol (30).Urine Pi concentration was 
determined by the phosphomolybdate method 
(29). 
 
Electron microscopy and immunogold labeling 
Mice were anesthetized with 2.5 % 
Isoflurane/pressurized air and perfused through 
the left ventricle with PBS (0.9% NaCl in 10 
mM phosphate buffer, pH 7.4) followed by 
paraformaldehyde-lysine-periodate fixative 
(PLP: 4% paraformaldehyde, 75 mM lysine 
HCl, 10 mM sodium periodate, and 0.15 M 
sucrose in 37.5 mM sodium phosphate)(31). 
After 5 minutes the kidneys were removed and 
postfixed for an additional hour on ice in the 
same fixative solution. Following fixation, the 
kidneys were stored at 4°C in PBS. 
For immunogold staining, small pieces of 
Rhcg
+/+
 and 
-/-
 kidneys were dehydrated 
through a graded series of ethanol to 100% 
ethanol and then embedded in LR White resin 
(Electron Microscopy Sciences, Fort 
Washington, PA, USA). Thin sections were 
incubated on drops of primary anti-V-ATPase 
(A-subunit, 1:200) antibody for 2 h. After 
rinsing with PBS, the grids were incubated on 
drops of goat anti-rabbit IgG coupled to 15nm 
gold particles (Ted Pella, Redding, CA, USA) 
for 1 h. Following several rinses with distilled 
water, the grids were stained with 2% uranyl 
acetate for 10 min, rinsed in distilled water, 
and dried. Sections were examined in a JEM-
1011 transmission electron microscope (JEOL 
Ltd, Tokyo, Japan).  
 
Immunoblotting - Crude total membranes were 
obtained from Rhcg
+/+
 and 
-/-
 mouse renal 
medulla homogenized in 250 mM sucrose, 10 
mM Tris-HCl, pH 7.5, and in the presence of 
protease inhibitors. Fourty micrograms of 
crude membrane proteins were solubilized in 
loading buffer containing 10% DTT and 
separated on 8 to 10% polyacrylamide gels. 
For immunoblotting, proteins were transferred 
electrophoretically to polyvinylidene fluoride 
membranes (Immobilon-P, Millipore Corp., 
Bedford, MA, USA). After blocking with 5 % 
milk powder in Tris-buffered saline/0.1% 
Tween-20 for 60 min, blots were incubated 
with primary antibodies: rabbit anti-mouse 
ATP6V1B1 (B1) (raised against the sequence 
CAQQDPASDTAL, Pineda Berlin, 1 :5,000), 
rabbit anti-ATP6V1B2 (B2) (raised against 
thesequence EFYPRDSAKH, Pineda Berlin, 
1 :5,000), rabbit anti-ATP6V0a4 (32), 1 :5000, 
rabbit anti-ATP6V0a1 (a kind gift of Dr Xie, 
Dallas, TX, USA) (33), 1 :5000, and mouse 
anti-ATP6V1E2 (a kind gift of Dr. S. L Gluck, 
University of California, San Francisco, CA, 
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USA), 1 :5000, and mouse monoclonal anti-β-
actin antibody (Sigma, St. Louis, MO; 
1:10,000) overnight at 4°C. After washing and 
blocking with 5 % milk powder for 60 min, 
membranes were incubated for 2 h at room 
temperature with secondary goat anti-rabbit or 
donkey anti-mouse antibodies 1:5,000 linked 
to alkaline phosphatase (Promega, Madison, 
WI, USA). The protein signal was detected 
with the appropriate substrate (Millipore Corp, 
Bedford, MA, USA) using the las-4000 image 
analyzer system (Fujifilm Life Science USA). 
All images were analyzed using Advanced 
Image Data Analyzer AIDA (Raytest, 
Straubenhardt, Germany) to calculate the 
protein of interest/β-actin ratio. 
 
Cell culture - HEK293 (human embryonic 
kidney) non transfected (HEK-WT) or stably 
transfected with human RhCG (HEK-RhCG) 
cell lines had beenpreviously generated (6) and 
grown at 37°C, 5% CO2 in DMEM 
(Dulbecco's modified Eagle's 
medium)/Glutamax I 
(Invitrogen)supplemented with 10% (v/v) fetal 
bovine serum. Selection of HEK-RhCG cells 
was performed in culture medium 
supplemented with 0.3 mg/ml hygromycin 
(Invitrogen). Forall pH experiments, cells were 
passaged, disseminated onto coverslips and 
grown to sub-confluency for 48 hours. The 
final medium exchange was performed 24 
hours before the experiments were started. 
Medium pH was maintained at pH 7.4. 
 
RNA extraction and reversetranscription - 
Snap-frozen kidneys (five kidneys for each 
condition) or  HEK-WT and HEK-RhCG cells 
(3 petri dishes of 5x10
6
 cells for each 
condition) were homogenized in RLT-Buffer 
(Qiagen, Basel, Switzerland) supplemented 
with β-mercaptoethanol to a final 
concentration of 1%. Total RNA was extracted 
from 200 μl aliquots of each homogenized 
sample using the RNeasy Mini Kit 
(Qiagen,Basel, Switzerland) according to the 
manufacturer’s instructions. Quality and 
concentration of the isolated RNA preparations 
were analyzed on the ND-1000 
spectrophotometer (Nano-Drop Technologies). 
Total RNA samples were stored at −80°C. 
Each RNA sample was diluted to 100 ng/μl 
and 3 μl used as a template for reverse 
transcription using the TaqMan Reverse 
Transcription Kit (Applied Biosystems, Forster 
City, CA, USA). For reverse transcription, 300 
ng of RNA template were diluted in a 40-μl 
reaction mix that contained (final 
concentrations) RT buffer (1×), MgCl2 (5.5 
mM), random hexamers (2.5 μM), RNase 
inhibitor (0.4U/μl), the multiscribe reverse 
transcriptase enzyme (1.25U/μl), dNTP mix 
(500 μM each), and RNase-free water. 
 
Reverse Transcription and semiquantitative 
real-time PCR -Semiquantitative real-time RT-
qPCR was performed on the ABI PRISM 7700 
Sequence Detection System (Applied 
Biosystems, Forster City,CA). Primers and 
probes were chosen using BLAST tool: 
Ensemble(http://www.ensembl.org/index.html) 
to result in amplicons no longer than 150 bp 
spanning intron-exon boundaries to exclude 
genomic DNA contamination. The specificity 
of all primers was first tested on mRNA 
derived from kidney and always resulted in a 
single product of the expected size (data not 
shown). Probes were labeled with the reporter 
dye FAM at the 5’ end and the quencher dye 
TAMRA at the 3’ end (Microsynth, Balgach, 
Switzerland). Primers and probes sequences 
are summarized in supplementary table 1. 
Real-Time PCR reactions were 
performed using TaqMan Universal PCR 
Master Mix (Applied Biosystems, Forster 
City,CA). Briefly, 3 μl cDNA, 0.8 μl of each 
primer (25 μM), 0.4 μl labeled probe (5 μM), 5 
μl RNAse-free water, and 10 μl TaqMan 
Universal PCR Master Mix reached 20 μl of 
final reaction volume. Reaction conditions 
were denaturation at 95°C for 10 min followed 
by 40 cycles of denaturation at 95°C for 15s 
and annealing/elongation at 60°C for 60s with 
auto ramp time. All reactions were run in 
triplicate. For analyzing the data, the threshold 
was set to 0.2 as this value had been 
determined to be in the linear range of the 
amplification curves for all mRNAs in all 
experimental runs. The expression of the genes 
of interest was calculated in relation to 
hypoxanthine guanine phosphoribosyl 
transferase (mouse HPRT or human HPRT). 
Relative expression ratios were calculated as R 
= 2
(Ct(HPRT) − Ct(test gene)
, where Ct represents the 
cycle number at the threshold 0.02.  
 
Intracellular pH (pHi) measurements on 
HEK293 cells - For pHi measurements, 
individual slides seeded with HEK-WT or 
HEK-RhCG cells were transferred into a 
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perfusion chamber (~ 3-5 ml/min flow rate) 
and mounted on an inverted microscope (Zeiss 
Axiovert 200, Carl Zeiss, Feldbach, 
Switzerland) equipped with a video imaging 
system (Visitron, Munich, Germany) for the 
duration of the experiment. The temperature of 
the chamber was maintained at 37°C by an 
electronic feedback circuit. The control bath 
solution was initially a HEPES-buffered 
Ringer solution (125 mM NaCl/ 5 mM KCl/ 1 
mM CaCl2/ 1.2 mM MgSO4/ 2 mM NaH2PO4/ 
32.2 mM HEPES/ 5 mM Glucose). Cells were 
loaded with the acetoxymethyl ester of the pH 
sensitive dye BCECF (10 µM, Invitrogen) for 
15 min and washed to remove all non-
deesterified dye. pHi was measured by 
microfluorometry by exciting the BCECF dye 
with a spot of light alternately at 490 and 440 
nm while monitoring the emission at 532 nm 
with a video-imaging system (34). H
+
-ATPase 
activity was measured after induction of 
anintracellular acidification using the NH4Cl 
(20 mM) prepulse technique (34). Bicarbonate-
free solutions were used and Na
+
 was replaced 
by N-methyl-D-glucamine (NMDG). Each 
experiment was calibrated for pHi using the 
nigericin/high K
+
 method (35) and the obtained 
ratios were converted to pHi. Na
+
-independent 
pHi recovery rates in response to an acid load 
were calculated in HEK293 wildtype and 
HEK293 RhCG stably transfected cells. Data 
are shown as changes in pHi (ΔpHi) per 
minute. 
 
Microperfusion of isolated cortical collecting 
ducts - Male Rhcg
+/+
, Rhcg
-/-
, Atp6v1b1
+/+
, and 
Atp6v1b1
-/-
 mice were given a HCl-containing 
diet (0.2 M HCl added to powdered standard 
food) in normal cages for 2 days. Mice were 
anesthetized with Xylazin/Ketamin i.p. Both 
kidneys were cooled in situ with control bath 
solution (see below) for 1 min and then 
removed and cut into thin coronal slices for 
tubule dissection. Cortical CDs (CCDs) were 
dissected from the cortex at 10°C in the control 
solution. 
 
Intracellular pHi measurement in 
microperfused cortical collecting ducts - The 
isolated tubule was transferred to the bath 
chamber on the stage of an inverted spinning-
disc microscope (IX81, Olympus, Japan) in the 
control solution containing (in mM) 138 NaCl, 
1.5 CaCl2, 1.2 MgSO4, 2 K2HPO4, 10 HEPES, 
5.5 glucose, 5 alanine, pH 7.40) and then, was 
mounted on concentric pipettes and perfused in 
vitro with Na
+
-free, ammonium-free solution 
where N-methyl-D-Glutamine
+
 (NMDG
+
) 
replaced Na
+
. The average tubule length 
exposed to bath fluid was limited to 300 – 350 
µm in order to prevent motion of the tubule. 
CCDs were loaded with 5 µM of the 
fluorescent probe BCECF (2’,7’-bis(2-
carboxyl)-5-(and-6)-carboxyfluorescein 
(Invitrogen, Switzerland) for ~20 min at 37°C 
in the control bath solution. The loading 
solution was then washed out by initiation of 
bath flow and the tubule was equilibrated with 
dye-free control bath solution for 5 min. Bath 
solution was delivered at a rate of 20 ml/min 
and warmed to 37°C by water jacket 
immediately upstream to the chamber. After 
this temperature equilibration in control 
solution, tubules were first transiently acidified 
by peritubular Na
+
 removal (Na-free, 
ammonium-free solution) (10 min duration), 
replaced by NMDG
+
 to avoid exit of NH4
+ 
by 
basolateralNa
+
-coupled transport. This 
maneuver was performed in the luminal 
absence of Na
+
. During the fluorescence 
recording, perfusion solution was delivered to 
the perfusion pipette via a chamber under an 
inert gas (N2) pressure (around 1 bar) 
connected through a manual 6-way valve. With 
this system, opening of the valve 
instantaneously activates flow of solutions. 
The majority of the fluid delivery to the pipette 
exits the rear of the pipette system through a 
drain port at 4 ml/min. This method results in a 
smooth and complete exchange of the luminal 
or the peritubular solution in less than 3 to 4 s 
(36). After the fluorescence signal 
stabilization, luminal medium was instantly (at 
the rate of 4 ml/min in the draining) replaced 
by a Na
+
-free solution containing 20 mM 
NH4Cl (and 118 mM NMDG-Cl) that elicited a 
rapid intracellular alkalinization, followed by a 
sharp acidification. The initial rate of 
intracellular alkalinization has been associated 
with the entry of NH3 whereas the subsequent 
phase of intracellular acidification in the 
continued presence of extracellular NH4Cl 
reflects mostly NH4
+
 entry (37). After the 
acidification reached a plateau, NH4Cl was 
removed from the lumen causing a further 
acidification of cells and initiating H
+
-
excretion with a maximum rate. The measured 
light intensities were digitized with the 
CellM&CellR Imaging hardware system 
(Olympus, Japan) for further analysis as 
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previously described (11-12,38). For 
peritubular ammonium pulses, peritubular the 
peritubular solution was changed to a 6 mM 
NH4Cl solution, pH 7.40 in the absence of 
sodium in bath and lumen. 
 
Intrinsic buffering capacity determination - 
The intrinsic buffering capacity (ßi) of CCD 
cells was determined for the Rhcg strain, as 
previously reported (11,26,39), using a 40 mM 
NH4Cl basolateral pulse to acidify the cells. To 
exclude HCO3
-
/CO2 as a buffering component 
and block Na
+
-dependent pHi regulatory 
mechanisms, Na
+
-free, HEPES-buffered 
solutions were used in perfusate and bath 
containing 1 mM amiloride and bath and 
perfusate also contained 100 µM Sch28080 
and 200 nM Concanamycin A. Addition of 40 
mM NH4Cl to the bath induced an increase 
followed by a decrease in pHi. Cellular 
buffering power (i) was measured in CCDs 
from Rhcg
+/+
 and Rhcg
-/-
 mice.  
 
Statistics - Statistical comparisons were tested 
by unpaired t-test using Graphpad Prism 
(GraphPad Software). P values < 0.05 were 
considered as statistically significant. 
 
RESULTS 
Rhcg
-/-
 mice show a reduced capacity to 
excrete H
+
 from kidney CCD cells - We 
recently showed in in vitro microperfusion 
experiments that collecting duct cells from 
Rhcg
-/-
 mice exhibited a reduced NH3 
transepithelial flux due to reduced apical and 
basolateral NH3 transport (11-12). Here, using 
the same approach, we assessed H
+
 transport 
activity in microperfused CCD from Rhcg
+/+
 
and  Rhcg
-/-
 mice challenged for 2 days with an 
HCl load in the food to maximize transport 
activities. Luminal NH3/NH4
+
 prepulses were 
performed and H
+
 transport activity was 
assessed from the pHi recovery rates after 
maximal intracellular acidification after the 
removal of NH4Cl from the lumen (32,40). The 
initial rate of alkalinisation reflects H
+
 
extrusion, mostly by H
+
-ATPases (32) (Figure 
1A). However, as the initial pHi values were 
different in CCDs from Rhcg
-/-
 and Rhcg
+/+
 
mice, we also measured intracellular buffering 
power and calculated H
+
 fluxes (JH
+
) across 
the membrane to directly compare transport 
rates. JH
+
 was greatly reduced in CCDs from 
Rhcg
-/- 
by 89% (32.6 ± 12.8 pmol/mm/min vs. 
3.6 ± 0.6 pmol/mm/min, p ≤ 0.0001) (Figure 
1B). Thus, the more alkaline urine observed in 
Rhcg
-/-
 during acid-loading results from 
impaired proton secretion along the collecting 
duct. 
 
The absence of RhCG alters B1 and B2H
+
-
ATPase subunit expression - Next, we 
investigated whether the reduced H
+ 
flux 
observed in microperfused CCDs from Rhcg
-/-
 
mice could be linked to altered expression of 
H
+
-ATPase subunits. We measured mRNA and 
protein expression levels of various subunits of 
the H
+
-ATPase. At the level of mRNA, we 
could not detect any variation of the 
intercalated cell-enriched B1 H
+
-ATPase 
isoform (Figure 2A), and more ubiquitous B2 
(Figure 2B) and a4 (Figure 2C) H
+
-ATPase 
isoforms between Rhcg
+/+
 and
 -/-
 mice. For 
protein detection, we isolatedmembrane 
fractions from medullary kidney tissue to 
enrich the fraction of H
+
-ATPases originating 
from intercalated cells. The protein abundance 
of the ubiquitous E2 (Figure 3C) and a1 
isoforms (Figure 3D) as well as the kidney-
enriched a4 (Figure 3E) subunits of the H
+
-
ATPase was not different between the 2 
genotypes. However, the amount of the 
intercalated cell-enriched B1 isoform (Figure 
3A) was increased whereas the ubiquitious B2 
isoform (Figure 3B) was decreased in 
membrane fractions from medullary kidney 
tissue of Rhcg
-/-
 mice (p≤ 0.01).  
 
The localization of H
+
-ATPases is not different 
in Rhcg
-/-
 intercalated cells - Reduced H
+
-
ATPase activity may result from altered 
subcellular localization of H
+
-ATPases. 
Kidneys from Rhcg
+/+
 and Rhcg
-/-
 acid-loaded 
for 2 days were examined by electron 
microscopy and immunogold staining for the 
ubiquitious A subunit (Figure 4). The absence 
of Rhcg did not affect the immunoreactivity 
for the A subunit in type  intercalated cells of 
Rhcg
-/-
 mice. H
+
-ATPase staining was detected 
mostly in intercalated cells and was associated 
with the luminal membrane as well as with 
intracellular vesicles as described previously 
(16). Thus, absence of Rhcg is not associated 
with an obvious redistribution of H
+
-ATPases 
in type  intercalated cells.  
 
The overexpression of RhCG in HEK293 cells 
increases H
+
 excretion rates - To test if the 
expression of RhCG was correlated with 
stimulation of H
+
-ATPase activity, we used 
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HEK293 cells, which express H
+
-ATPases and 
exhibit H
+
-ATPase-mediated proton secretion 
across the membrane (41). Untransfected 
HEK293 cells and HEK293 cells stably 
transfected with human RhCG were used to 
measure H
+
-ATPase activity. qRT-PCR 
confirmed high expression levels of RhCG in 
RhCG-transfected HEK293 cells as reported 
previously (Figure 5A) (5). 
Following NH4Cl prepulse acidification in a 
HCO3
-
 and Na
+
 free solution, we measured 
intracellullar pH recovery rates, similar to 
experiments in microperfused CCDs (Figure 
5A). We have previously demonstrated that 
this pHi recovery is mediated solely by H
+
-
ATPases and sensitive to the H
+
-ATPase 
blocker bafilomycin (41). The initial 
intracellular pH of both groups of cells 
measured was in the same range (pH 7.16 ± 
0.001 for untransfected HEK293 cells and 7.18 
± 0.002 for RhCG expressing RhCG cells),  
which allowed us to compare directly 
ΔpHi/Δt.In HEK-RhCG cells, the rate of pHi-
recovery observed after NH4Cl removal was 52 
% higher than the one observed in wildtype 
HEK 0.020 ± 0.003 pH units/min vs. 0.042 ± 
0.003 pH units/min (p≤ 0.01). This result 
suggests that the presence of RhCG can 
stimulate H
+
 secretion and is in agreement with 
our data showing that H
+
 secretion is impaired 
in collecting ducts from Rhcg
-/-
 mice. Finally, 
we compared the expression levels of genes 
encoding different subunits of the vacuolar H
+
-
ATPase, ATP6V1B1 (Figure 6A), ATP6V1B2 
(Figure 6B) and ATP6V0A1 (Figure 6C), and 
found an exclusive increase in mRNA 
expression of ATP6V1B1 in HEK-RhCG 
compared to HEK-WT cells (Figure 6A). 
 
Concanamycin A inhibits H
+
-ATPases activity 
and apical NH3 permeability - To further 
examine the functional interaction between 
RhCG and H
+
-ATPases, we used the H
+
-
ATPase inhibitor concanamycin (200 nM) in 
microperfused CCDs from wildtype mice 
receiving a NH4Cl acid-load for 2 days. 
Concanamycin reduced pHi recovery rates 
from 0.13 ± 0.02 pH units/min to 0.06 ± 0.01 
pH units/min indicating that H
+
-ATPases 
contribute to pHi recovery as reported 
previously (28,32,42) (Figure 7A, control = 10, 
concanamycin n = 5). Concanamycin A also 
reduced apical NH3 permeability from 2.48 ± 
0.35 pH units/min to 0.41 ± 0.11 pHunits/min 
as measured from initial alkalinization rates 
(Figure 7B, control n = 10, concanamycin n= 
5). 
 
Lack of the Atp6v1b1 H
+
-ATPase subunit 
reduces H
+
-ATPase activity without effect on 
NH3 permeability - The results from the 
concanamycin A experiment offered at least 
two different interpretations: inhibition of H
+
-
ATPase activity reduces Rhcg-mediated NH3 
permeability or concanamycin A acts 
independently on H
+
-ATPase and Rhcg 
activities. In order to distinguish between these 
two possibilities, we used a genetic animal 
model with reduced H
+
-ATPase activity, mice 
lacking the Atp6v1b1 (B1) subunit 
(19,28,43).As a consequence of their genetic 
impairment, Atp6v1b11
-/-
mice receiving HCl 
acid-loading diet showed a more alkaline 
urinary pH compared to Atp6v1b1
+/+ 
mice 
(Figure 8A and Supplementary table 1) as 
described previously (19). Urinary NH4
+
 
excretion was comparable between both 
genotypes before and during acute HCl 
treatment. However, after 4 days of the diet, 
Atp6v1b1
-/- 
presented a 23% reduction of NH4
+
 
excretion (Figure 8B). To assess whether 
collecting ducts from Atp6v1b11
-/-
mice had 
altered NH3 permeability, we performed 
microperfusion studies on isolated CCDs from 
Atp6v1b1
+/+
 and
-/-
mice receiving 2 days of HCl 
diet. We confirmed the expected reduction in 
H
+
 secretion in Atp6v1b1
-/-
mice when NH4Cl 
was applied from the tubular lumen (Figure 
8C) but were not able to detect any differences 
in NH3 membrane permeability across the 
apical (Figure 8D) or basolateral (Figure 8E) 
membranes. Thus, in a genetic model, reduced 
H
+
-ATPase activity is not paralleled by 
reduced apical or basolateral NH3 
permeability.  
 
DISCUSSION 
 Intercalated cells in the renal 
collecting duct secrete NH3and protons. NH3 
secretion occurs also from neighbouring 
segment-specific cells of the distal convoluted 
tubule and connecting tubule expressing the 
water channel AQP2, the epithelial channel 
ENaC, and Rhcg (7,9,11). Parallel NH3 and 
proton secretion are intricately linked: high 
luminal proton concentrations are required to 
protonate NH3 trapping NH4
+
 in urine, whereas 
buffering of protons by titratable acids such as 
phosphate or creatinine together with 
protonation of NH3 ensures that urinary pH 
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does not become too acidic, generating an 
unfavorable pH gradient for further H
+
-ATPase 
activity.  
  
Mice with a total deficiency of Rhcg 
excrete more alkaline urine during acid-
loading (11-12). This observation suggested a 
defect in urinary acidification since reduced 
secretion of ammonia due to the deletion of 
Rhcg should result in rather more acidic urine. 
Our results demonstrate that Rhcg stimulates 
H
+
-ATPase function and that in its absence H
+
-
ATPase activity is reduced explaining the more 
alkaline urine and possibly contributing to the 
more pronounced metabolic acidosis in Rhcg 
deficient mice. Here we demonstrate that i) in 
microperfused collecting ducts from Rhcg
-/-
 
mice, H
+
-ATPase activity is greatly reduced, 
ii) the deletion of Rhcg does not alter mRNA 
abundance of major H
+
-ATPase subunits, iii) 
loss of Rhcg does not affect the apparent 
subcellular localization of H
+
-ATPases in 
intercalated cells, iv) absence of Rhcg alters 
the relative abundance of the B1 and B2 H
+
-
ATPase isoforms with B1 being upregulated, 
v) overexpression of Rhcg in renal HEK293 
cells is sufficient to stimulate H
+
-ATPase 
activity paralleled by increased B1 mRNA 
abundance, vi) pharmacological inhibition of 
H
+
-ATPases with concanamycin blocks H
+
-
ATPase and Rhcg transport activity, and vii) 
that genetic reduction of H
+
-ATPase activity in 
mice lacking the B1 H
+
-ATPase subunit 
reduces only H
+
-ATPase activity but not Rhcg 
mediated NH3 permeability. 
 
Rhcg deficient mice have reduced H
+
-
ATPase activity as evident from more alkaline 
urine and in vitro microperfusion experiments 
demonstrating lower H
+
-fluxes. Similar 
findings have been made in Atp6v1b1
-/-
 and 
Atp6voa4
-/-
 mouse models with genetic 
deletion of single subunits of the H
+
-ATPase in 
intercalated cells (19,23,28,43). H
+
-ATPase 
activity is regulated by different mechanisms 
including phosphorylation of the A subunit, 
trafficking of pumps into and out of the 
membrane, and possibly changes in 
composition of distinct subunit isoforms and 
their abundance (15-16,44-46). However, 
subcellular localization of H
+
-ATPase was not 
different between genotypes. Moreover, the 
abundance of several H
+
-ATPase subunits was 
similar for both groups of animals. Only the 
abundance of the intercalated cell enriched B1 
isoform was higher and the expression of the 
B2 isoform reduced. This is in contrast to mice 
lacking the B1 isoform (Atp6v1b1
-/-
), which 
have an upregulation of the B2 isoform but a 
decrease of several H
+
-ATPase subunits in 
intercalated cells. The B1 and B2 isoform may 
serve different roles and B2 cannot replace B1 
as evident from lack of stimulation of H
+
-
ATPases containing only the B2 isoform 
(28,43). The upregulation of B1 protein 
abundance may thus rather reflect an attempt 
to compensate for the loss of H
+
-ATPase 
function in Rhcg
-/-
 than cause reduced H
+
-
ATPase activity.  
 
In order to gain more insights into the 
effect of Rhcg on H
+
-ATPase function, we 
used the renal HEK293 cell line stably 
transfected with human RhCG (5). We have 
previously shown that these cells express a 
functional H
+
-ATPase at the plasma membrane 
and that H
+
-extrusion in the absence of 
extracellular sodium and bicarbonate is only 
mediated by H
+
-ATPases (41). In 
vitrooverexpression of RhCG demonstrated 
higher H
+
 extrusion. Furthermore, several H
+
-
ATPase subunits were detected at mRNA level 
in untransfected and RhCG expressing 
HEK293 cells and only ATP6V1B1 mRNA 
was increased.  Thus, overexpression of RhCG 
stimulates membrane-associated H
+
-ATPase 
activity in a heterologous system similar to the 
in vivo situation. 
  
 To study reciprocally the effect of H
+
-
ATPases on RhCG activity in the collecting 
duct, we employed a pharmacological and 
genetic approach. In a first series of 
experiments, we used concanamycin A, an 
inhibitor of H
+
-ATPase activity (47-48). 
Concanamycin A reduced pHi-recovery rates 
in intercalated cells in microperfused 
collecting ducts by more than 50 % in 
agreement with previous studies (28,49). 
However, apical NH3 permeability mediated 
by Rhcg was also drastically reduced. This 
reduction was not due to altered pH gradients 
that could potentially affect the rate of 
deprotonation of NH4
+
 to NH3 and the driving 
force of NH3 transport through Rhcg. Thus, 
these results suggested that either H
+
-ATPase 
activity modulates Rhcg activity or that 
concanamycin A acts directly or indirectly on 
Rhcg independent from its inhibitory effect on 
H
+
-ATPases. Therefore, we used in a second 
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series of experiments, mice lacking the B1 
isoform of H
+
-ATPases (Atp6v1b1
-/-
) that is 
specifically enriched in intercalated cells. H
+
-
ATPase function in the intercalated cells from 
these mice is reduced but not totally abolished 
(19,28,50). Microperfusion of collecting ducts 
confirmed reduced H
+
-ATPase activity but 
found not evidence for altered apical or 
basolateral Rhcg mediated NH3 permeability. 
In agreement with these data, we found also 
only a minor reduction in urinary ammonium 
excretion in acid-loaded Atp6v1b1
-/-
 mice after 
4 days. This reduction may be explained by the 
reduced driving force for NH3 secretion and 
decreased trapping of NH4
+
 due to the less 
acidic urine. Thus, the effect of concanamycin 
A on NH3 permeability is most likely the result 
of unspecific inhibition of Rhcg activity. 
Concanamycin A is a highly lipophilic 
substance accumulating in the plasma 
membrane and may thereby interact with Rhcg 
independent from its effects on H
+
-ATPases. 
Moreover, our results provide no evidence for 
modulation of Rhcg activity by H
+
-ATPases 
beyond the generation of pH gradients 
favorable for NH3 transport.  
  
 In summary, we show that Rhcg 
functionally interacts withthe activity of the 
vacuolar H
+
-ATPase and enables intercalated 
cell to enhance the secretion of 
protons.Absence of Rhcg reduces H
+
-ATPase 
activity and fully explains the excretion of 
more alkaline urine by Rhcg
-/-
 even in the 
absence of ammonium, a major urinary buffer.  
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FIGURE LEGENDS 
 
FIGURE 1.H
+
-secretion from cortical collecting duct cells of Rhcg
-/-
 mice is reduced. 
Cortical collecting duct were isolated from kidneys of Rhcg
+/+
 and Rhcg
-/-
 mice after 2 days of 
HCl-loading, microperfused in vitro, and intracellular pH (pHi) monitored in cortical 
collecting duct with BCECF-AM. NH4Cl (20 mM) was applied from the luminal perfusate. 
(A) Original pHi tracing from a CCD exposed to a luminal NH4Cl pulse. The arrow indicates 
the rate of pHi changing measured and calculated. Exposure to an NH4Cl pulse caused a large 
acidification of the cells followed by pHi recovery. The initial slope (∆pHi/∆t) of the 
alkalinization phase was measured and H
+
 fluxes were calculated based on intracellular 
buffering power (see methods section). (B) Bar graph summarizing H
+
 fluxes after removal of 
the luminal NH4Cl pulse (n = 8-12 tubules/genotype). 
 
FIGURE 2.mRNA expression of the B1, B2 and a4 subunits of the H
+
-ATPase in Rhcg
+/+
 
and Rhcg
-/-
 mice is unchanged.RT-qPCR was performed in total kidney to determine relative 
mRNA levels of several H
+
-ATPase relevant for intercalated cell H
+
-ATPase function. None 
of the mRNA values measured of the B1 (A), B2 (B) and a4 (C) isoforms was different 
between the 2 genotypes. Values are mean ± SEM (n= 5 mice/genotype). 
 
FIGURE 3.Increased B1 and decreased B2 H
+
-ATPases protein levels in Rhcg
-/-
 mice. 
Protein expression of the B1 (A), B2 (B), E2 (C), a1 (D) and a4 (E) subunits of the H
+
-
ATPase was assessed by Western blotting in the medullary kidney tissue. In Rhcg
-/-
 mice, B1-
H
+
-ATPase protein abundance was upregulated (A), while B2 H
+
-ATPase was downregulated 
(B). Protein expression of the a1, a4, and E subunits remained unchanged (C-E). Values are 
mean ± SEM (n= 5 mice/genotype), ***p ≤ 0.001.  
 
FIGURE 4.Subcellular localization of the vacuolar H
+
-ATPase in type A intercalated cells 
of kidney collecting ducts from Rhcg
+/+
 and Rhcg
-/-
 mice is similar. 
(A,B) Immunogold staining for the A subunit of the H
+
-ATPase revealed a similar density of 
H
+
-ATPases at the apical membrane and in apically localized vesicles of type A intercalated 
cells in Rhcg
+/+
 (A) and Rhcg
-/-
 (B) mice. Scale bars: 2μm. (A’,B’) Magnification of the 
respective area of the overview electron micrograph in A and B. Scale bars: 0.5 μm. The 
asterisk indicates the luminal side. A dashed line indicates the lateral cell borders. 
 
FIGURE 5.RhCG overexpression in renal HEK293 cells increases H
+
 excretion. 
H
+
-ATPase activity was measured in untransfected HEK293 cells and HEK293 cells stably 
transfected with human RhCG using the NH4Cl (20 mM) prepulse after loading cells with 
BCECF. (A) Overexpression of RhCG was confirmed by RT-qPCR. (B) Original pHi tracings 
from untransfected HEK293 (WT) and RhCG overexpressing HEK293 cells. Dashed lines 
indicate the slope measured to calculate pHi changes over time.(C) Bar graph summarizes the 
H
+
 extrusion rate of HEK-WT compared to HEK-RhCG after NH4Cl pulse (n = 5 cells/plate, 
3 dishes/condition). Data are mean ± SEM, **p ≤ 0.01, 
 
FIGURE 6.ATP6V1B1 mRNA is increased in HEK293 cells overexpressing RhCG. 
mRNA expression of ATP6V1B1 (A), ATP6V1B2 (B) and ATP6V0A1 (C) were measured 
by RT-qPCR in untransfected HEK293 (HEK-WT) and HEK293 overexpressing RhCG 
(HEK-RhCG) cells. ATP6V1B1 mRNA was higher in HEK-RhCG cells versus HEK-WT. 
The mRNA abundance of the other H
+
-ATPase subunits, ATP6V1B2 (B) and ATP6V0A1 
(C), were unchanged. Values are mean ± SEM (n= 5 dishes/cell type), *p ≤ 0.05 
 
FIGURE 7. Concanamycin A reduces H
+
-ATPase activity and apical NH3 permeability in 
CCDs from wildtype mice. Cortical collecting duct were isolated from kidneys of wildtype 
mice after 2 days of NH4Cl-loading and microperfused in vitro. Intracellular pH (pHi) was 
monitored with BCECF-AM and cells were challenged with a luminal NH4Cl (20 mM) 
prepulse in the presence or absence of 200 nM Concanamycin A in the lumen. (A)Bar 
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graphsummarizing the rate of realkalinization after NH4Cl removing from the lumen 
corresponding to H
+
 secretion.. (B)Bar graphsummarizing the rate of alkalinization after 
addition of NH4Cl corresponding to NH3entry into the cells. (controln = 10 
tubules;concanamycin n = 5 tubules). *, p<0.05 ; C : control, ConA : Concanamycin A. 
 
FIGURE 8.Atp6v1b1
-/-
 mice lacking the B1 H
+
-ATPase subunit have decreased H
+
-ATPase 
activity but preserved apical and basolateral NH3 permeabilities. 
Widltype (Atp6v1b1
+/+
) and Atp6v1b1
-/-
 mice were observed in metabolic cages and urinary 
pH (A) and urinary ammonium excretion normalized to creatinine (B) monitored during 
baseline and an acid-load (HCl) for 4 days  (n = 7/genotype). Cortical collecting ducts from 
mice acid-loaded for 2 days were microperfused in vitro and H
+
 secretion (C) and apical NH3 
permeability (D) measured after a luminal NH4Cl prepulse (20 mM) (n = 10 
tubules/genotype). (E) Similarly, basolateral NH3 permeability assessed after an NH4Cl 
prepulse from the bath (6 mM) was not different between genotypes (n = 6 tubules/genotype). 
*p ≤ 0.05 
 
 
SUPPLEMENTS 
 
Supplementary table 1. Sequences of the primers and probes of the gene expressions 
evaluated by RT-qPCR 
 
Supplementary table 2. Blood values in Atp6v1b1
+/+
 mice and Atp6v1b1
-/-
 mice under 
normal diet and HCl load for 4 days. Data are presented as mean ± SEM, n = 5-9 animals/ 
group, * p<0.05 vs baseline period in same genotype, 
#
 p<0.05 vs C57BL6 mice during the 
same period. 
 
Supplementary table 3. Weight, food intake and urinary values in Atp6v1b1
+/+
 mice and 
Atp6v1b1
-/-
 mice under normal diet and during an HCl load for 4 days. Data are presented as 
mean ± SEM, n = 5-9 animals/ group, * p<0.05 vs baseline period in same genotype, 
#
 p<0.05 
vs C57BL6 mice during the same period. 
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Supplementary data 
Supplementary table 1. Primers and probes sequences of the gene expressions evaluated by RT-qPCR 
Gene Accession 
number 
Forward primer Reverse primer Probe 
Mouse 
Atp6v1b
1 
NM_13415
7 
5’-
CCCAGTATGCTGAGATTGTCAACTT
TACCCTCC -3’ 
5’- 
CCTGAACAATGGCCTTGGTC-3’ 
5'-
CCCAGTATGCTGAGATTGTCAACTTTA
CCCTCC-3' 
Mouse 
Atp6v1b
2 
NM_00750
9 
5’- 
GCTGGTGATCCTGACGGACA 
TGAG-3’ 
5’-
CGTGCCGGTCGAGTGGAAGGTA
GAAACGG-3’ 
5’- 
CTGCGAGAGGTTTCAGCTG-3’ 
Mouse 
Atp6V0
a4 
NM_08046
7 
5’- 
GACGGTGTCTCATCTATGGTTTGA-
3’ 
5’- 
TTTGCCCTGCATGGTCTTGTC-3’ 
5'- 
TCTCTCCATTATCAAGAGCTCATGCCA 
-3' 
Mouse 
Hprt 
NM_01355
6 
5′-
TTATCAGACTGAAGAGCTACTGTA
AGATC-3′ 
5′-
TTACCAGTGTCAATTATATCTTC
AACAATC-3’ 
5'-
TGAGAGATCATCTCCACCAATAACTTT
TATGTCCC-3' 
Human 
RhCG 
NM_01632
1 
5’- CTACCGACGCAACCTAGAGC-3’ 5’-GCTGTCCCCATGGTAGGATA-3 5’-CTTTGCCATGATTGGCACCC-3’ 
Human 
ATP6V1
B1 
NM_00169
2 
5’-GAGATGATTCAGACGGGCATTT-
3’ 
5’-CTGGTGAAGAAGTCCAAGGC-
3’ 
5’-AATGAGATTGCCGCTCAGAT-3’ 
Human 
ATP6V1
B2 
NM_00169
3 
5’’-
TGAAGGGACTTCAGGTATAGATGC-
3’ 
5’-GGAAGTCTTCGGCCAGTACA-
3’ 
5’-TGGTCGGGTATTCAATGGAT-3’ 
Human 
ATP6V0
A1 
NM_00113
0020 
5’-TTCCTGGAACTGACCGAATTA-3’ 5’-AGGAGTGCCTCTTCCCATCT-3’ 5’-GAGGCTGAATTGCATCATCA-3’ 
Human 
HPRT 
NM_00018
5 
5’-AAGGGTGTTACGTTTAT-3’ 5’-TATTTCCTGTGCGTGAT-3’ 5'- ACCTCCTTGGGATCTATTTCACCG -
3' 
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Supplementary table 2. Blood values in Atp6v1b1
+/+ 
mice and Atp6v1b1
-/-
 mice under normal diet and HCl load for 4 days 
 
  Basal status 2 days HCl 4 days HCl 
  
C57BL6 
(n=9) 
Atp6v1b1
-/-
 
(n=7) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=6) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=5) 
pH 7.35 ± 0.01 7.40 ± 0.01 7.11 ± 0.02* 7.15 ± 0.02* 7.24 ± 0.02 6.87 ± 0.12*
#
 
pCO2 (mmHg) 40.0 + 0.6 40.6 ± 1.2 37.3 ± 1.2 39.3 ± 1.5 39.4 ± 1.5 45.4 ± 2.5
#
 
HCO3 (mM) 21.6 + 0.7 24.8 ± 1.2 11.5 ± 0.8* 12.8 ± 0.6* 16.4 ± 0.9* 8.7 ± 1.8*
#
 
pO2 52.1 ± 2.2 48.8 ± 2.0 60.4 ± 2.4 62.6 ± 3.4 58.4 ± 2.5 83.8 ± 8.7*
#
 
Na
+
 (mM) 144.6 ± 0.5 145.4 ± 0.3 148.0 ± 1.1* 147.8 ± 1.5 151.4 + 0.5* 150.8 ± 2.4* 
Cl
-
 (mM) 109.7 ± 0.6 108.3 ± 0.7 123.4 ± 1.6* 121.0 ± 1.5* 120.0 ± 1.6* 133.6 ± 2.8*
#
 
Ca
2+
 (mM) 1.26 ± 0.01 1.23 ± 0.01 1.34 ± 0.01* 1.33 ± 0.02* 1.36 ± 0.02* 1.60 ± 0.1*
#
 
Hb (g/dl) 15.1 ± 0.2 15.7 ± 0.2 15.6 ± 0.3 16.7 ± 0.2*
#
 15.3 ± 0.2 18.8 ± 1.2*
#
 
 
 
* p<0.05 vs baseline period in same genotype, 
#
 p<0.05 vs Atp6v1b1
+/+
  mice during the same period. 
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Supplementary table 3. Weight, food intake and urinary values in Atp6v1b1
+/+
 mice and Atp6v1b1
-/-
mice under normal diet and during an HCl load 
for 4 days 
 
 
Basal status 2 days HCl 4 days HCl 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=7) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=7) 
C57BL6 
(n=7) 
Atp6v1b1
-/-
 
(n=5) 
Weight (g) 22.7 ± 0.28 28.1 ± 0.5
# 
20.4 ± 0.2* 24.6 ± 0.3*
#
 20.5 ± 0.3* 23.0 ± 0.3*
#
 
Weight lose in % of body weight under basal status 0.1 ± 0.6 0.4 ± 0.9 10.3 ± 0.5* 13.0 ± 1.6*
#
 11.9 ± 3.4* 18.8 ± 2.7*
#
 
Food intake (g/24hrs/body weight) 0.36 ± 0.01 0.36 ± 0.02 0.28 ± 0.01* 0.22 ± 0.03* 0.34 ± 0.04 0.26 ± 0.01*
#
 
Water intake (ml/24hrs/body weight) 0.17 ± 0.05 0.05 ± 0.01
#
 0.20 ± 0.05 0.20 ± 0.04* 0.18 ± 0.03 0.23 ± 0.06* 
Urine values       
volume (ml/24 h) 2.6 ± 0.4 3.0 ± 0.1 2.1 ± 0.2 4.7 ± 0.8
#
 3.1 ± 0.2 3.9 ± 1.2 
creatinine excretion (µmol/24 h) 3.7 ± 0.6 3.4 ± 0.2 3.4 ± 0.4 1.8 ± 0.3*
#
 1.9 ± 0.2* 1.9 ± 0.7* 
Urinary pH 6.2 ± 0.0 6.5 ± 0.1
#
 5.4 ± 0.1* 6.0 ± 0.0*
#
 5.7 ± 0.1* 6.0 ± 0.1*
#
 
UNH4/UCr (mEq/mmol) 3.4 ± 0.3 11.3 ± 1.2
#
 51.0 ± 2.0* 56.7 ± 13.8* 88.9 ± 6.2* 76.6 ± 7.2*
#
 
UPi/UCr (mEq/mmol) 13.1 ± 1.1 11.6 ± 0.7 14.3 ± 2.4 18.8 ± 3.2 16.4 ± 2.6 22.7 ± 5.2 
 
* p<0.05 vs baseline period in same genotype, 
#
 p<0.05 vs Atp6v1b1
+/+
 mice during the same period.
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V  Discussion 
 
V.1 Implications of RhCG in disease 
 
 When RhCG-mediated NH3 secretion was demonstratedin vivoby Biver 
and co-workers in 2008 asa critical pathway enabling final urinary acid 
excretion, RhCG appeared as a promising candidate involved in orphan 
dRTA7.  Since then, the phenotype of Rhcg+/- mice was studied and revealed 
that one missing copyof the Rhcg gene is enough to induce incomplete 
metabolic acidosis39. This data reinforced our interest for looking for mutations 
ofRhCG in dRTA patients who might more likely harbour heterozygous 
abnormalities of RhCG. However, the spectrum of severity found in dRTA is 
large ranging from the absence of symptoms when not challenged,to major 
effects in infancy with severe acidosis, impaired growth, and early 
nephrocalcinosis causing eventually renal insufficiency47. To date, no 
mutation of RhCG in humans has been linked to dRTA despite directly 
sequencing RhCG in a cohort of more than 50 patients with orphan dRTA 
(personal communication Vargas, R., Wagner, C.A., Houillier, P.). 
Furthermore, the two studies that raised the hypothesis of RhCG mutations in 
dRTA were performed on mice receiving NH4Cl or HCl acid treatment, both 
considered as strong experimental acid-loads which are unlike physiological 
conditions7,39. Hence, it became of major interest to studyRhcg mutant 
animals in more commonly occurringconditions of increased urinary NH4
+ 
excretion resembling what potential RhCG mutant patients could face. 
 
 Rhcg-/-mice receiving a dietary acid-load of high animal protein diet, 
which approximated the typical western diet, were able to implement 
compensatory mechanisms in order to adapt the acid-load created by the 
metabolism of high protein. Rhcg heterozygous mice acid-base status was not 
affected by high protein intakes. Considering these data, it is tempting to 
speculate that the effect of RhCGmutations in humans would also be 
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compensated in physiological acid-loading conditions, preventing the 
apparition of a disturbance of the acid-base status in the mutation carriers, 
therefore decreasing further the chances to correlate RhCG to a pathological 
setting.  
 
 Nevertheless, the relevance of RhCG for the clinics may apply for other 
aspects. In normal kidneys, diets rich in animal proteins have been linked to 
the development of tubular-interstitial injury63, and are generally suspected to 
have several negative impacts on renal function68.In Rhcg-/- mice fed western 
diet-like high casein, the compensation mechanisms observed in the kidney 
proximal tubule and TAL were amplified compared to the response of normal 
kidneysto the same diet. Hence, one can speculate that human kidneys 
lacking RhCGor having reduced expression, in the long term, could develop 
chronic kidney disease from compensating their defect. The ability of normal 
kidneys to excrete acids progressively decreases with increasing age84. This 
phenotype might appear earlier or be more severe in humans harbouring a 
mutation of RhCGcompared to a normally aging population. 
 
 Moreover, we observed in Rhcg-/-an exaggerated bone resorption 
compared to the effect of high protein diet in animals with normal kidneys. 
Although the effect of the absence of Rhcg on bone measured in Rhcg-/- mice 
was not severe in these 3 months old animals, further experiments conducted 
on older animals receiving a longer high protein treatment than 9 days might 
reveal a stronger effect. This data raisealso the possibility of the implication of 
RhCG in bone pathologies. Among bone diseases, osteoporosis, which is 
characterized by a reduction in bone mass and a deterioration of bone 
architecture, appearing after the age of fourty85 could constitute a possible 
consequence of RhCG impairment. Multiple causes lead to osteoporosis such 
as estrogene deficiency found in post-menauposal women, reduced vitamin D 
and increased PTH production or local factors and signalling molecules 
reducing bone formation or increasing resorption86. In Rhcg-/-, higher levels of 
the bone resorption marker deoxypyrydinoline were paralleled by 
hypercalcemia, suggesting a possible altered status of vitamin D/PTH axis in 
the mice. 
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V.2 Regulation of RhCG expression and activity 
 
 Following analysis and interpretation of the data presented in three 
aimsof this dissertation we can suppose that different types of regulation of 
RhCG might exist. 
 
 Wildtype mice receiving 9 days high protein diet acid-load showed a 
transient increase in Rhcg mRNA levels suggesting that acidosis might induce 
a transcriptional regulation of Rhcg expression or an increase in Rhcg mRNA 
stabilization. The forkhead transcription factor Foxi1 is highly expressed in 
intercalated cells of kidneys and mice deficient for Foxi1 develop dRTA87. 
Furthermore, in intercalated cells of kidneys, Foxi1 is required for the 
expression of the A1, E2 and a4 subunits of the vacuolar H+-ATPase88. 
RhCG, which is necessary to the normal function of vaculoar H+-ATPasesin 
type-A intercalated cells of kidney CCDs, could also be a potential target of 
Foxi1. However, preliminary data indicate that Foxi1-/-mice do not show 
reduced expression of Rhcg mRNA (Kampik N.B., unpublished results). In 
Foxi1-/- total kidney, the level of Atp6v1b1 mRNA is highly reducedand no B1 
protein can be detected by immunofluorescence in the distal nephron 
epithelia.The effect ofFoxi1on Rhcg protein expression is not known but it is 
likely that Rhcg protein abundance is not altered. 
 
 Studies in rat receiving a chronic HCl acid-load revealed that apical 
membrane abundance of Rhcg in OMCDs and in the base of the inner 
medulla are increased89. In the OMCD, this enhanced staining resulted from 
both increased total protein and changes in the subcellular distribution of 
Rhcg90. Hence, Rhcg function might also be regulated by trafficking, enabling 
a sustained adaptation to chronic metabolic acidosis. However, the exact 
mechanisms underlying this regulation have not been investigated yet. 
 
 As discussed before, metabolic acidosis alters gene expression and 
cellular localization of proteins involved in renal acid elimination but can also 
influence hormonalpathways as well as paracrine signalling. In response to 
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metabolic acidosis, the angiotensin II-aldosterone axis, as well as endothelin, 
show an increased production.  
 
 While glucocorticosteroids enhance ammoniagenesis in the proximal 
tubule, the distal tubule is the recognized site for the action of 
mineralocorticoids. In type-A intercalated cells of kidneys, aldosterone, but 
also angiotensin II91, which stimulates aldosterone release in the adrenal 
gland, are strong stimuli for the activity of vacuolar H+-ATPases91,92. The 
effect of both hormones appears to be mediated by intracellular Ca2+ 
increases activating H+-ATPases in a Protein Kinase C dependent 
manner93,94. A similar pathway involving either aldosterone, angiotensin II or 
both could possibly regulate Rhcg activity and enhance the functional 
partnership observed between Rhcg and vacuolar H+-ATPases in the 
collecting duct of kidney following an acid-load. Furthermore, in high protein 
acid-loaded kidneys, enhanced activity of H+-ATPases by aldosterone was 
also reported following increased levels of the vasoactive substance 
endothelin63. 
 
 Endothelin 1 was first discoveredas a potent endothelial-derived 
vasoconstrictor as well as a sodium-regulating peptide95. In kidneys, epithelial 
cells of the collecting duct are able to synthetize endothelin (ET1)
95 and 
express endothelin receptors B (ETB)
97. Systemic but also paracrine 
production of endothelin 1 is increased during metabolic acidosis. 
Interestingly, ET1 paracrine production is also increased during a high protein 
diet, which leads to an acid load without blood gas disturbance63. In the 
proximal tubule, the apical Na+/H+ exchanger NHE3, which is involved in 
NH4
+secretion and HCO3
- reabsorption in this nephron segment, is increased 
by ET1/ETB receptors in response to metabolic acidosis
98. RhCG activation 
mediated by ET1/ETB receptor inthe kidney collecting duct cells might exist 
and explain, at least in part, the origin of higher NH4
+ excretion observed in 
mice after a high protein acid-load. 
 
 More paracrine factors such as nitric oxide (NO) or prostaglandinscould 
constitute plausible regulators of RhCG function. Nitric oxide is synthetized 
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endogenously from from L-arginine by various nitric oxide synthase (NOS) 
enzymes and is a powerful vasodilatator, a central nervous system 
neurotransmitter and plays also a role in immunity99. In intercalated cells of 
kidney CCDs, NO is produced by an inducible form of NOS and responsible 
for the inhibition of vacuolar H+-ATPases activity100, which might decrease the 
driving force of Rhcg mediated NH3 passage. Prostaglandins are derived from 
the metabolism of arachidonic acid and produced by the action of the 
cyclooxygenase (COX) enzyme. In the kidney, they are produced in various 
nephron segments but thecollecting duct is the major site of renal 
prostaglandin production. Most of the available evidence indicates that the 
predominant effect of prostaglandins on renal function involves salt and water 
transport. Prostaglandin E2 (PGE2) appears to be involved in both water 
excretion and absorption but the underlying mechanisms are not fully 
understood and likely depend on which receptor is activated under a particular 
physiologic condition101. Studies in rat also revealed that prostaglandinsinhibit 
NH3 synthesis in normal and mild metabolic acidosis conditions
102. However, 
the role of prostaglandins in acid excretion by the renal collecting duct system 
has not been yet investigated. Our study of the response of Rhcg+/+, Rhcg+/- 
and Rhcg-/-miceto acidogenic high protein diet revealed altered urine 
concentration and urinary NH4
+ excretion in Rhcg-/- versus wildtype. This 
response could reflect a particular action of PGE2 on Rhcg.  
 
V.3 Molecular pathways of urinary NH4
+ excretion in 
intercalated cells of kidney 
 
 In the third aim of the dissertation, we tried to detail the molecular 
pathway leading to the excretion of NH4
+ in the intercalated cells of kidneys. 
Our first hypothesisof a potential partnership between Rhcg and the vacuolar 
H+-ATPase was based on the evidence of the predominant role of Rhcg and 
H+-ATPases in achieving urinary NH4
+ excretion and the fact that Rhcg-/- mice 
excrete more alkaline urine. Our data in microperfused CCDs of Rhcg+/+ and -
/- mice and in the in vitro model of HEK cells overexpressing RhCG and 
wildtypetested this hypothesis and indicate that Rhcg enhances the activity of 
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the vacuolar H+-ATPase. However, the mechanism underlying this effect is 
still unclear. In microperfused CCD of rabbit kidneys, intracellular 
NH3levelsincrease H
+-K+-ATPase-mediated proton secretion, and not 
vacuolar H+-ATPase-mediated proton secretion103. This stimulus of the H
+/K+-
ATPase activitymost likely worksthrough increased insertion of the H+/K+-
ATPase at the apical membrane mediated by vesicule associatedsoluble N-
ethylmaleimide-sensitive fusion attachment receptor proteins (vSNARE)104.In 
metabolic acidosis, the role of H+/K+-ATPases in acid excretion by collecting 
ducts becomes minor compared to vacuolar H+-ATPases105. However, the 
more alkaline urine of Rhcg-/- mice is also detected at baseline7. Further 
experiments assessing the activity of the H+/K+-ATPase in Rhcg-/- mice in 
different conditions (baseline or following an acid-load) might help to 
understand better the mechanisms underlying the reduced proton excretion 
observed in Rhcg-/- mice. 
 
 The study performed on Rhcg-/- mice challenged with high casein 
acidogenic protein diet detailed further the mechanisms involvedin the renal 
collecting duct to manage a physiological acid-load. We showed that in the 
absence of Rhcg, a compensation of its lack exists,from the increased 
production of NH4
+ to theshunting of its accumulation in the renal interstitium, 
whichis enough to allow a proper urinary NH4
+ excretion. We described in 
Rhcg-/-mice a mechanism of shunting interstitial NH4
+ reabsorption prior to 
distal tubule transepithelial passage to enable a direct elimination of NH4
+. 
However, this process might not fully explain how the lack of Rhcg mediated 
NH3 transport does not impair final NH4
+ formation in the lumen. The passive 
NH3 diffusion across kidney CD cells might be different, or, another protein 
involved in NH3 permeability in the collecting duct might exist.Genome-wide 
studies performed in mice receiving either 0, 4 or 7 days NH4Cl acid-load 
enabled to uncover genes involved at various levels of the response to 
metabolic acidosis, including SNAT3, PDG and PEPCK106. A similar approach 
comparing the expression levels of the collecting duct genes of Rhcg-/- in 
conditions where the potential candidate involved in Rhcg compensation 
seems to be highly expressed such as chronic high casein protein diet, with 
conditions where increased urinary NH4
+ excretion is not required such as 
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non-acidogenic high soy protein diet, might reveal unknown genes involved in 
urinary NH4
+ excretion in the collecting duct. 
VI Conclusion and perspectives 
 
 The present study confirmed that RhCG has a pivotal role in renal 
management of metabolic acid loads, revealed the importance of the protein 
in physiological acid-loading conditions and provided evidence for its 
concerted action with renal vacuolar H+-ATPases in urine 
acidification.Notwithstanding, the question of RhCG relevance in pathology 
remains open. Likewise, the regulation of RhCGexpression and activity 
remains to be further elucidated and might provide a further molecular 
explanation for the collecting duct response to acid-base disturbances, a 
response obviously involving NH3 permeability mechanisms still unknown. 
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